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Abstract 
Many researchers have documented the trend of decreasing financial support from donors 
for human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) 
responses in Ethiopia. Less information is available regarding the correlation between 
trends of HIV prevalence and external funding and ways to address the impact that 
funding scarcity could cause. The purpose of this study was to examine the trend of HIV 
prevalence and donor funding levels, analyzing how the 2 are correlated, and 
opportunities to improve responses. Using the proximate determinant framework, the 
research questions examined the changes in HIV prevalence in Ethiopia during the past 
10 years; the association between the trends of HIV prevalence, funding levels, and 
services provided; and the effect of different characteristics on the trend of the 
prevalence. A paired sample t-test, time series forecasting, Pearson correlation, chi-
square test, and multiple regression were employed using a secondary data of sampled 
1,067 people from the Demographic and Health Surveys and data from donors. Results 
indicated that the change in prevalence was statistically significant (t [10] = 4.59, p = 
.001), and correlated with the funding levels(r (10) = .635*, p = .027), a significant 
relationship between funding level and type of services, χ2 (2, N = 1067) = 1425.7, p 
<.001 and a significant regression equation to predict HIV prevalence (F (9, 1056) = 
12.639, p < .001). The results from this study could be used to inform the Ministry of 
Health of Ethiopia and HIV project implementers to plan for domestic sustainable 
financing initiatives, invest based upon evidence-based HIV prevention strategies that 
could most directly impact quality of life and guide future research. 
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Section 1: Foundation of the Study and Literature Review 
Substantial improvements have been documented regarding integrated Human 
Immunodeficiency Virus (HIV)prevention and care services in many countries as huge 
investments were targeting to provide integrated HIV prevention and treatment services 
across the HIV care continuum (The Joint United Nations Programme on HIV/AIDS 
[UNAIDS], 2017). However, because of decreases in funding, the possibility of relapse 
of HIV pandemic is feared not to cause universal crisis and looming future progress 
(United Nations General Assembly, 2016). One of the challenges is an ongoing funding 
gap for HIV/AIDS programs. According to UNAIDS (2017), while $19 billion was 
estimated to be accessible from domestic and international sources to address the problem 
of low and middle income countries in the year 2016, this need for additional money will 
increase to $26.2 billion by 2020 and the funding level to meet UNAIDS’s global targets 
to end AIDS as a global public health threat will be gradually reduced by 9% by 
2030(Stover, 2016). 
According to PEPFAR (2013), though the total funding (bilateral and multilateral) 
from the US government addresses the global HIV epidemic, since 2010, PEPFAR 
funding levels have remained essentially flat or decreasing for some countries in Africa. 
According to UNAIDS (2017), ending HIV/AIDS depend largely on the funding level 
and ability of each country to provide HIV treatment to all who need it. Samji (2013) said 
that defunding the HIV/AIDS program may cause catastrophic phenomena.  
Poverty is a barrier for the achievement of HIV prevention (Shelton, 2005). 
Poverty, underdevelopment, lack of choices for services, and the inability to determine 
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one’s own destiny fuel the HIV epidemic (UNAIDS, 2001). According to Fenton (2004), 
poverty leads people to high-risk behaviors and reducing poverty is the only viable long-
term response to the epidemic. 
In Africa, the prevalence of HIV correlates directly with wealth and there is a 
strong positive correlation between household wealth and national income with HIV 
infection prevalence across sub-Saharan Africa (PEPFAR, 2005).Since HIV’s discovery 
in 1981, more than 25 million people have died of AIDS. Worldwide, 33 million people 
are currently HIV positive, leading to a global adult prevalence of 0.8% (UNAIDS, 
2008). Sub-Saharan Africa has the highest HIV prevalence at 5%, which makes up two-
thirds of the worldwide HIV burden (World Health Organization [WHO], 2016).  
In Ethiopia two decades ago, there were 3 million HIV infected people, and an 
estimated 280,000 people died of AIDS (UNAIDS, 2000). This was the largest infected 
population worldwide after South Africa and India, and HIV/AIDS was one of the key 
challenges for overall economic and human resource developments (DHS, 2011). Based 
on a single point estimate, which is an estimate of unknown population parameter by 
using sample data to calculate a single value (FMOH, 2007); currently in Ethiopia with  a 
population of 105 million, adult HIV prevalence is estimated to be 1.1%, and the 
incidence rate is 0.29% (The Ethiopian Public Health Institute [EPHI], 2017). Prevalence 
and incidence rates also significantly vary between geographical areas and gender 
(Federal HIV/AIDS Prevention and Control Office [FHAPCO], 2008).The prevalence of 
AIDS in the Gambella region is 6.6%, while in Addis Ababa it is 5%, and in the Southern 
Nations, Nationalities and Peoples’ region it is 0.7%. Moreover, while urban prevalence 
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in Ethiopia is 7.7%, rural prevalence is estimated to be 0.9%; in both areas, young 
women remain at very high risk of HIV infection(Elsevier, B., 2016).The burden of HIV 
in Ethiopia is decreasing because substantial advances have been made to increase access 
to testing and treatment of HIV in many high-burden regions, prevent mother-to-child 
transmission, integrate HIV services with Maternal and Child Health (MCH) services, 
retention and Antiretroviral Therapy (ART) adherence, reduce stigma and discrimination, 
increase social support, and mobilize communities (Kendall & Danel, 2014). 
In this study, a 10-year trend analysis of HIV prevalence and funding levels from 
donors for HIV/AIDS prevention and control activities in Ethiopia reviewed the link 
between funding level and HIV treatment, care, and support services as well as how and 
where domestic funds or national budgets are to be spent to address the epidemic, reduce 
new infections, reduce AIDS related deaths, and eliminate stigma and discrimination 
when funding from donors for HIV/AIDS program was declining. Consequently, the 
potential positive social change implication of this study is health programmers, policy 
makers, and researchers will be benefited because the finding of the study articulated 
where the HIV epidemic is heading, how the trend of the epidemic correlated with the 
funding levels allotted every year from donors for prevention, care, and support activities; 
the change in HIV prevalence for different population subgroups, the relationship 
between the type/number of services being given to control HIV/ADS and the funding 
levels; and  if the prevalence has a similar trend to all Socioeconomic and Demographic 
Characteristics. After knowing the aforementioned changes, health programmers and 
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policy makers can strategize the prevention responses and resources accordingly for 
efficient and effective measures that enable to stop the spread and death of HIV/AIDS. 
Problem Statement 
In the prevention and control measures of HIV/AIDS, donor funding has a 
significant role in developing countries (Kates, Lief, & Wexler, 2014). Donors in this 
study are international grant making foundations providing funding resources and 
technical assistance to help developing countries as they design and implement their 
program strategies to fight HIV/AIDS. Sub-Saharan Africa has the greatest number of 
recipient countries of any region and received the largest share of assistance from donors 
(57% of global HIV/AIDS funding) and had the largest number of donors (Bendavid, 
2012). Ethiopia accounts for 8% of funding from 27 donors in Sub-Saharan Africa and 
the donor community has made remarkable support in the HIV/AIDS response (Kates, 
Michaud, & Wexler, 2013). 
However, currently, financial support from donors for HIV/AIDS response in 
low-income countries including Ethiopia is being reduced (Garmaise, 2015). Specifically, 
funding from PEPFAR, one of the successful anti-HIV/AIDS programs in Ethiopia, is 
severely declining and likely to affect the availability of HIV drugs and other HIV/AIDS-
related assistance. Currently, because of this budget cut, many HIV prevention, care, and 
support programs are being phased out or scaled back prematurely, which is a problem 
that triggered this study. To address this problem and achieve the goal of ending HIV as a 
public health threat by 2030, some priority strategies like intensifying coordinated HIV 
prevention efforts, undertaking high impact targeted prevention activities, and targeted 
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HIV counseling and testing are being taken (HAPCO, 2016); however, despite this, 
shortage of resources is still a problem and affects the development programs of 
HIV/AIDS, the community conversation initiatives on prevention strategies at the 
community level, capacity development and policy support at national HIV/AIDS 
councils support of decentralized HIV/AIDS responses at regional and district levels, the 
support that civil society organizations (CSOs) had for HIV/AIDS responses, generation 
of knowledge on HIV through research activities, mainstreaming the integration of 
HIV/AIDS prevention activities into other programs’ activities, the provision of ART for 
million infected people, support for HIV test laboratories, TB/HIV surveillance, support 
for orphan and vulnerable children (OVC), infrastructure, and trainings (Kates et al., 
2013). 
A possible factor contributing to these problems, phasing out of HIV programs 
and scaled back scopes, is the decrement of global donor support as the result of 
increasing funding demands such as humanitarian emergencies and refugee crises 
combined with ongoing fiscal austerity in many countries (UNAIDS & Henry, 2016). For 
instance, between 2014 and 2015, 13% HIV funding level decrement have been reported 
globally (UNAIDS, 2017). This study will contribute to the body of knowledge needed 
and significant to the health discipline to address the problem by analyzing the change in 
prevalence of HIV in Ethiopia in relation to changes in donors funding levels and 
recommend high impact activities with available resources to people with different 
socioeconomic and demographic characteristics. 
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Background 
Ethiopia is the second most populous country in Africa after Nigeria, with a 
population of 102 million in 2016 (World Bank, 2017). Despite impressive economic 
growth, Ethiopia remains a low-income country with a real per capita income of $505 
and 31%of the population lives below the international poverty line of $1.25/day (World 
Bank, 2017). According to the UN (2014), Ethiopia ranks 173 out of 187 countries both 
the overall index and per capita gross national income (GNI), which shows the country’s 
poor economy and general low standard of living. Life expectancy is estimated at just 
65.5 years (63.7 for males and 67.3 for females), which gives Ethiopia a world life 
expectancy ranking of 141 (WHO, 2018). The inflation of 26% remains a problem for 
most poor people and there are thousands of street children in the capital city, Addis 
Ababa, alone. It is also one of the least urbanized countries, with 82% of the population 
living in rural areas (World Bank, 2016).  
The HIV/AIDS situation in Ethiopia continues to be a mixed epidemic with 
significant heterogeneity across geographic areas and population groups (Federal 
Ministry of Health [FMOH], 2007). The Ethiopia Demographic and Health Survey of 
2011 (DHS2011),a nationally-representative household survey that provides data for a 
wide range of monitoring and impact evaluation indicators in the areas of population, 
health, and nutrition, estimated national HIV prevalence at 1.5%, compared to 2.4% . 
Among the surveyed households, 56% of women and 55% of men have never been tested 
for HIV (DHS, 2016). This is an indication that the current number of HIV-positive 
individuals in the country could be a lot more had all the population been tested. 
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Moreover, despite the existence of 1.2 million people living with HIV/AIDS, 72% are 
thought to be aware that they are living with the virus; the remaining 28% think they are 
not infected (DHS, 2016).  
In order to address these problems, HIV care and treatment services have been 
expanded rapidly and this was reflected in the massive scale-up of ART access to people 
living with HIV from 96,897 in 2006 to 450,000 at the end of 2016 (WHO, 2016). This 
success was accompanied by an unprecedented increase in resources from the donor 
community (UNAIDS & Henry, 2016). During the time when the nature of the epidemic 
and its fueling factors creates a complex challenge to the ability of health and other 
sectors to meet the targets and control HIV/AIDS in full, the financial supports from 
dedicated donors and the commitment from the government of Ethiopia had enabled the 
HIV prevention measures bringing considerable progresses and achieving encouraging 
results (UNAIDS, 2013).There are numerous aid organizations in Ethiopia that provide 
development aid and address global health and other social and economic development 
issues. However, according to UNAIDS (2008), the United States under PEPFAR is now 
the largest HIV prevention government donor globally, which accounts for 54% of 
international funding. In its first 5years, PEPFAR prevented more than 740,000 AIDS-
related deaths in the African countries in which it worked and had, on average, almost 
halved general mortality in people living in these countries (Bendavid, 2012). In 
Ethiopia, during 2011 and 2012, total spending on HIV/AIDS was $405 million, of which 
86% ($350 million) came from donors and 64.5% of it was from PEPFAR (UNAIDS, 
2013).  
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While the Ethiopia government is committed to achieving universal access to 
treatment for those in need, funding for HIV from PEPFAR has begun to flat line, and 
international contributions from other donors is declining while the fund shortage is 
increasing exponentially (UNAIDS, 2013). To mitigate this problem, ways of boosting 
funding have been dealt among stakeholders in the past by calling for more donor 
coordination, increasing traction of donors’ interest by providing empirical evidence that 
their donations change lives and make desired impact on the lives of people, and 
undertaking high impact targeted HIV prevention activities. Donors’ coordination is 
imperative to use available funds for interventions that are cost-effective and capable to 
avert a high number of HIV infections compared with uncoordinated uses of the funds 
(Kahn & Marseille, 2000).The information recognized on the association between HIV 
prevalence and funding levels would provide evidences for the rational allocation of 
resources for the right target groups and increases the likelihood of utilizing new funds 
efficiently in the future. Otherwise, if funding for HIV remains at its current level or if 
PEPFAR, the largest supporter, in the global fight against HIV and AIDS makes drastic 
cuts to its level of support, HIV deaths and new infections can be expected to rise in 
concentrated, generalized, and hyper endemic settings (Piot, 2015). 
As a result of the global response to HIV, 20 million people are now receiving 
ART and both new infection and mortality rates have been declining (WHO, 2016); this 
was happening mainly because of the support from PEPFAR (Vogus & Graff, 2015). 
Conversely, in order to reach the UNAIDS 90-90-90 goals by 2020, which is that 90% of 
persons with HIV will know their HIV status, 90% of persons with HIV will receive 
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sustained ART, and 90% of persons receiving ART will achieve viral suppression 
(UNAIDS, 2017), the available funding for it seems inadequate and threatening the hope 
of achieving the goal as it is being declining. 
In addition to PEPFAR, funding decrements have been noticed among some 
significant global donors including the U.K. Department for International Development 
(DFID), the Global Fund to Fight AIDS, Global Fund for Tuberculosis and Malaria, Bill 
and Melinda Gates Foundation, and Australia’s Department of Foreign Affairs and Trade 
(DFAT; Formerly AusAID) (Kates et al., 2014). The DFID is cutting all of its bilateral 
HIV funding to middle income countries (Murphy & Podmore, 2014). From 2010 to 
2014, PEPFAR began a transition process in 12 countries in the Eastern Caribbean 
(PEPFAR, 2010; Vogus & Graff, 2015) as well as South Africa, Botswana, and Namibia 
(Brundage, 2011). The Global Fund for HIV prevention has deemed 11 countries 
ineligible for further HIV funding based on their income status and disease burden 
(Garmaise, 2015).  
Meanwhile, according to Office of Global AIDS Coordination [OGAC] (2016), 
even though Ethiopia has focused on efforts that could sustain epidemic control by 
decreasing the numbers of new infections and AIDS-related deaths, deficiencies or gaps 
have been observed in terms of consolidating gains achieved to date, continuing program 
realignment, consolidating implementing partners, and focusing on country ownership.  
In addition, there was no study showed how HIV prevalence is associated with donor 
funding levels, and what type or/ number of services or responses the country’s strategic 
plan should focus on to control the HIV/AIDS epidemic during decrements of funds by 
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applying critical enablers like programming in areas such as human rights, community-
based capacity building, targeting, and retention in care.  
As a result, at this time, when there is less financial support from external donors, 
unless the country develops strategies that can maintain the momentum of success, there 
is no guarantee of avoiding a relapse of the epidemic because of funding level 
diminishment. Hence, this will be a critical time to target HIV prevention activities with 
evidence, establish strong coordination between existing donors, strengthen internal 
financial sources, leverage available financial sources, avoid duplication of efforts, and 
foster greater transparency to support country ownership. To do this all, analyzing the 
trend of HIV prevalence and funding from donors for anti-HIV/AIDS activities and their 
effects on health and social outcomes to all socioeconomic and demographic 
characteristics is paramount to designate effective measures that could bring desired 
changes like reducing death rate due to HIV and controlling the transmission of the virus  
with limited resources. Otherwise, insufficient human resources, feeble supply of 
management and distribution, and weak midlevel managerial capacity at regional and 
district levels will continue challenging Ethiopia’s response to HIV/AIDS. 
Accordingly, this study has shown where the HIV epidemic is currently heading 
and how this correlated with the funding level allotted every year from the donor 
community for HIV prevention, care, and support. In addition, it analyzed whether the 
changes in prevalence was statistical significant; evaluated the relationship between the 
type/number of services or responses to control HIV/AIDS and the funding levels; and 
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examined the difference in prevalence among different socioeconomic and demographic 
characteristics.   
Purpose of the Study 
The purposes of this secondary data analysis, quantitative study, were to explore 
if funding level from donors’ community is a proximate determinant for prevalence 
change, analyzing if the funding shortfalls threaten the gains made during the life of the 
Fund, and also if there is an association between the declining funding level and the 
change in prevalence of HIV/AIDS. It also compared the dependent and independent 
variables of each research question. The study focused on how the level of funding from 
donor communities was changing the quality and quantity of HIV/AID prevention and 
controlling activities; and what needs to get prior attention in the national HIV/AIDS 
control program when the budget level is continue declining. The approach, 
understanding the change in level of funding from donor community, aligns with the 
prevention and control measures of HIV/AIDS. This quantitative analysis has helped to 
identify the tendency of funding level, and indicated the type and number of services that 
need to be provided in high prevalence regions of the country within the available 
resources. This study recommended effective HIV/AIDS controlling activities that need 
to be given priority in the national HIV/AIDS control program of Ethiopia in resource 
constrained settings secondary to the budget reduction or budget cut from the donors’ 
community.  
The potential positive social change implication of this study finding is informing 
the healthcare decision-makers with findings of the four research questions so that they 
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will place more value on such works in their deliberations and in their interactions with 
stakeholders for sustainable financing initiatives. It also will help to bring changes in the 
system of implementation; and find the best solutions to HIV epidemic control and 
prevention strategies, which is the most burdensome health problems, by meet the long-
term needs of people living with problem. In addition, it will have an important role of 
supporting the transfer of knowledge between the researcher and healthcare decision-
makers to bring valuable and positive social changes in social structure and lead a more 
context sensitive, adaptive, and innovative responses. 
The role of donors, especially the PEPFAR, in the Ethiopia HIV epidemic control 
is significantly high; and because of such supports, the epidemic in the past decade has 
shown a trend of stabilizing and subsequently declined from 12.4% to 1.1% in between 
2001 and 2016 in both urban and rural areas where >85% of the population lives (EPHI, 
2017). Such changes in trends are encouraging and represent the commitment of the 
government and the contribution of collective concerted efforts across the numerous 
stakeholders involved in the Mutli-Sectoral HIV/AIDS responses (FHAPCO, 2012). 
However, because of a dip in donor HIV spending from $7.7 billion in 2009 to $6.9 
billion in 2010, and $4.9 billion in 2016, it becomes clear that many countries’ that heavy 
reliance on donor funding could not continue (UNAIDS & Henry Family Foundation, 
2017).  
Likewise, yearly, more than 86% of the total spending on HIV/AIDS in Ethiopia 
was came from external sources; and PEFPAR was the greatest contributor, forming 
greater than 50% of total spending on HIV/AIDS (UNAIDS, 2013); however, this 
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funding level from PEPFAR-Global Fund peaked in 2010, and has decreased by almost 
50 percent since 2012 (Office of the United States Global AIDS Coordinator [OGAC], 
2016); and this has negatively affected the interventions.  
Accordingly, the finding of this study has answered the research questions and 
contributed an effort to the HIV prevention and control program by proposing new 
approach on HIV control activities for targeted population groups and better geographic 
targeting of resources and a greater focus on the highest-impact prevention strategies that 
need to be addressed with limited resources in the process of transitioning away from 
reliance on external funding in favor of greater domestic investment for HIV without 
significant backsliding away from successes. In addition, it outlined the major areas of 
emphasis for future programming based on the review it made on the trend of HIV/AIDS 
prevalence among different socioeconomic and demographic characteristics; and donors 
supported Anti-HIV/AIDS activities and their effect on health and social outcomes. It 
also showed efficient and effective ways in speeding up progress in achieving the 
ambitious global targets of zero new infection, zero stigma and discrimination, and zero 
deaths due to AIDS with limited or local resources in the study area. 
Research Questions and Hypotheses 
RQ1: How has HIV prevalence changed in Ethiopia during the past 10years? 
H01: HIV prevalence in Ethiopia shows no difference during the past 10years. 
Ha1: There is a statistically significant difference between the HIV prevalence of 
the past 10years in Ethiopia. 
RQ2: How does the trend of HIV prevalence associate with funding from donors? 
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H02: There is no relationship between funding from donors and the trend of HIV 
prevalence.  
Ha2: There is a relationship between donors’ financial support to fight HIV/AIDS 
in Ethiopia and HIV prevalence trends.  
RQ3: What is the relationship between the type/number of services being 
provided to prevent and control HIV/ADS and funding from donors? 
H03: The type and number of services being provided to prevent and control 
HIV/ADS in Ethiopia have no relationship with the yearly funding levels from the donor 
community. 
Ha3: There is a relationship between the type and number of services being 
provided to prevent and control HIV/ADS in Ethiopia and the yearly funding levels from 
the donor community. 
RQ4: What was the effect of different socioeconomic and demographic 
characteristics on the trend of HIV prevalence in the past 10years? 
H04: HIV prevalence in the past ten 10years show similar trends among all 
socioeconomic and demographic characteristics. 
Ha4: HIV prevalence in the past 10years show different trends among different 
socioeconomic and demographic characteristics. 
Theoretical Foundations for the Study 
The proximate determinant is a quantitative framework that was first applied by 
John Bongaarts, a Dutch demographer, in the 1970s (James, 2006). The framework was 
used to study the relationship between factors, biological and behavioral, that impact 
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fertility including economic and environmental variables; and in turn, these external 
variables influence fertility. Bongaarts established an equation to define the impact of the 
most important proximate determinants on the outcome. This frame work has been 
applied broadly in the study of fertility and child survival in developing countries 
(Boerma & Weir, 2005). The key to the Proximate Determinant framework is recognizing 
of a group of variables that can be affected by changes in related variables or by 
interferences that have immediate effects on outcomes. According to James J C. (2006), 
the proximate-determinants framework can be used in HIV/AIDS study design, risk 
factors analysis and interpretation of findings. Accordingly, in this study, the proximate-
determinants framework has been applied to examine the prevalence of HIV/AIDS and 
funding level from donors for Anti-HIV/AIDS activities. The rational for choosing this 
framework was because it examines the association of proximate variables, like funding 
level for Anti-HIV/AIDS activities, with prevalence and if that has a direct effect on 
other outcomes and influences the change of other variables. The framework incorporates 
terms that are easily interprets and has been widely utilized as a theoretical model for 
HIV prevention and health promotion. 
This study was a trend analysis of HIV prevalence using secondary data from 
demographic and health surveys (DHS) done between 2005 and 2016, and from 
expenditure analysis data from HIV/AIDS program implementing partners in Ethiopia, 
and from data base of some health facilities. After considering the complexity of this 
study, the data were analyzed for each research question independently from different 
sources. The trend analysis model was useful, from national level perspective, guiding 
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the understanding to promote for targeting the right persons by examining whether the 
prevalence changing over time, and whether these trends differ among the predominant 
age, sex, racial/ethnic groups and be affected disproportionally by the HIV epidemic. It 
also enhances country ownership, creating a resilient system during budget cut, which 
ultimately enable to select the right HIV/AIDS responses for the right target groups.  
Characteristics                    Proximal determinants           Outcome   
 
 
 
 
 
  
 
 
 
Figure 1.Conceptual framework on the proximate determinants of HIV prevalence trend. 
Nature of the Study 
This was a descriptive and correlational study that used a quantitative research 
method for quantitative variables (HIV/AIDS prevalence, PEPFAR Funding level, 
demographic characteristics, etc.) to determine if there is a relationship between the 
prevalence of HIV/AIDS in Ethiopia and the declining funding level from donors. 
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the HIV/AIDS epidemic in Ethiopia was used from secondary data sources. The data on 
amount of funding levels from major donors focused on HIV/AIDS in the mentioned 
period were obtained from the data base of Federal Ministry of Health (FMoH) and 
FHAPCO. Accordingly, the necessary data collected from these institutions had enabled 
the researcher to answer the research questions including whether the donors support to 
fight HIV/AIDS was related to the prevalence or burden of the disease or not. In addition, 
a ten-year expenditure data from major program implementing partners were analyzed to 
know if the type and number of services to prevent and control HIV/AIDS were 
considering the variation of funding levels of each year or whether that was similar in all 
years by comparing services provided to different population groups.  
To see any alteration in the HIV/AIDS prevalence in the past ten years in relation 
to socioeconomic and demographic characteristics, data collected by Central Statistics 
Agency (CSA) for Demographic and Health Survey (DHS) 2005, 2011, and 2016 were 
used. In addition, The records of 1000 pregnant women 15 to 24-Year-Old attending two 
ANC clinics of public health facilities in Bishoftu and Addis Ababa from January 2006 to 
June 2016, and screened for HIV antibodies, were analyzed to see the trend of HIV/AIDS 
prevalence and to triangulate the result from DHS data findings. Equally, the socio-
demographic, behavioral and HIV-related data were analyzed using regression and 
bivariate and multivariable analyses were conducted to determine the factors that are 
independently associated with HIV-positive status. Data were analyzed using SPSS 
version 24. 
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The researcher’s rationale behind selecting these design and data sources was that 
both were readily available, quickly obtainable, and economical. Furthermore, using 
these secondary data from different sources helped to triangulate findings, improved the 
understanding of the problems. It also provided a basis for comparison of the data 
collected in different years so as to answer the research questions well.  
Literature Search Strategy 
The process of literature review for this study included assessing pertinent peer-
reviewed articles from the globe, Africa, and Ethiopia using both manual and electronic 
exploration methods.  Different search engines and databases like: UNAIDS/WHO 
Global HIV/AIDS Online Database, U.S. Census Bureau HIV/AIDS Surveillance Data 
Base, MEASURE/ORC MACRO Demographic and Health Surveys, the Ethiopia 
Demographic and Health Survey [EDHS] database, Medline, PubMed, Google Scholar, 
and Popline/One Source were used to search and identify appropriate studies. The 
websites of different organizations and other relevant sources were also explored 
manually. The search for appropriate studies used terms like prevalence, funding, 
services, HIV, response, socioeconomic, demographic, Spending, trend, donors, and 
other combinations: most-at-risk populations,  vulnerability, HIV/AIDS, trend-analysis, 
Anti-HIV/AIDS, prevalence –rate, AIDS-Spending, and PEPFAR-spending.  
Literature Review 
Prevalence Changes 
HIV continues to be a major global public health issue. In 2016, an estimated 36.7 
million people were living with HIV (including 34.5 million adults, 17.8 million women 
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(15+ years), and 2.1 million children (<15 years) – with a global HIV prevalence of 0.8% 
among adults (UNAIDS, 2017).  Around 30% of these same people do not know that 
they have the virus (UNAIDS, 2016). 
Since the start of the epidemic, an estimated 76.1 million people have become 
infected with HIV and 35 million people have died of AIDS-related illnesses. In 2016, 1 
million people died of AIDS-related illnesses (UNAIDS, 2017), and 1.8 million people 
became newly infected. There has previously been concern that the annual number of 
new infections among adults would remain static, as incidence rates failed to shift 
between 2010 and 2015; while new HIV infections among children globally have halved, 
from 300,000 in 2010 to 160,000 (47%) in 2016(UNAIDS, 2017). However, a slightly 
positive trend is emerging as new infections among adults are now estimated to have 
declined by 11% (1.9 million to 1.7 million) - and 16% for the general population - 
between 2010 and 2016, whereas there was only an 8% decline between 2010 and 2015. 
As of June 2017, 20.9 million (56.9%) people (54% of adults aged 15 years and 
older and 43% of children aged 0–14 years) were accessing antiretroviral therapy (ART). 
In 2016, the percentage of pregnant women living with HIV who accessed antiretroviral 
medicines to prevent transmission of HIV to their babies was 76%.  As a result of the 
improved coverage of ART and other HIV services, death rate due to AIDS has declined 
globally from 2005 to 2016 by 48% (1 million died in 2016 while it was 1.9 million in 
2005) (UNAIDS, 2017). 
Almost all countries worldwide are affected by the HIV epidemic. No region of 
the world has been spared. Although the epidemic is global, there is a remarkable 
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regional variation in its distribution. Some regions are highly affected by the epidemic as 
compared to other regions. The vast majority of people living with HIV are located in 
low- and middle- income countries, with an estimated 25.5 million living in sub-Saharan 
Africa. Among this group 19.4 million are living in East and Southern Africa which saw 
44% of new HIV infections globally in 2016(UNAIDS, 2017). 
Sub-Saharan Africa (SSA) is also one of the hot spots where HIV AIDS is widely 
spread and it is more hard hit by the consequences of epidemic than other parts of the 
world. It is the region where the highest number of victims of HIV/AIDS is found. Out of 
the 36.7 million people living with HIV worldwide, 69% live in sub-Saharan Africa 
(UNAIDS, 2017). There are roughly 23.8 million infected persons in all of Africa (WHO, 
2015), and 91% of the world’s HIV-positive children are also in this continent. 
According to the United Nation classification of ‘generalized epidemic’ about 90% of the 
countries which are located in Sub-Saharan Africa are severely affected by the epidemic. 
This epidemic has remained the major cause of death in this region.  
Although the Africa accounts only for 16.6% of the world population 
(Worldmeter, 2018), two-thirds of the total people living with HIV (24.5 million) are 
Africans, of whom 15 million have already died. Sub-Saharan Africa carries a 
disproportionate burden of HIV, accounting for more than 70% of the global burden of 
infection. Of the estimated 1.8 million individuals worldwide who became newly infected 
with HIV or from the 5,000 new infections per day, two out of three are in sub-Saharan 
Africa with young women continuing to bear a disproportionate burden (UNAIDS, 
2016).  The newly infected children (<15 years) with HIV includes 160,000 and most of 
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these children live in sub-Saharan Africa and were infected by their HIV-positive 
mothers during pregnancy, childbirth or breastfeeding. 
In eastern and southern Africa young women (aged 15–24 years) remain at 
unacceptably high risk of HIV accounted for 26% of new HIV infections in 2016 (WHO, 
2016). Countries in North Africa and the Horn of Africa have significantly lower 
prevalence, as their populations typically engage in fewer high-risk cultural patterns that 
have been implicated in the virus's spread in Sub-Saharan Africa (Gray, 2007). Southern 
Africa is the worst affected region on the continent (UNAIDS, 2012). As of 2011, HIV 
has infected at least 10 percent of the population in Botswana, Lesotho, Malawi, 
Mozambique, Namibia, South Africa, Swaziland, Zambia, and Zimbabwe (UNAIDS, 
2012). 
Meanwhile, with increasing access to ART, the number of AIDS related deaths 
have steadily declined and in sub-Saharan Africa these decreased by 39% between 2005 
and 2013 (UNAIDS, 2015). In South Africa alone the decline was 51% whereas in 
Ethiopia it was 37% and in Kenya it was 32%. Several empiric studies from South 
Africa, Uganda, Tanzania, Rwanda and Malawi have demonstrated that the impact of 
modest ART coverage at CD4 cell counts ranging from <200 to 500 cell per µl resulted 
in significant declines in mortality with life expectancy increasing by an additional 10 
years (Herbst, 2009).These studies provide evidence on the benefits of early ART 
initiation to HIV positive individuals. 
HIV/AIDS was first recognized in Ethiopia in the year 1984 (HAPCO, 2005), and 
the first hospitalized AIDS patients informed in 1986 (Lester, 1988). During those early 
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times, the epidemic was restricted only in urban areas and among certain population 
groups in specific commercial routes. Four years later, high HIV prevalence noticed in 
commercial sex workers and distance truck drivers, which were 17% and 13%, 
respectively (Mehret, 1990). A prevalence of 24.7% was also reported among sex 
workers of some urban areas in 1988 and this number rose rapidly in Addis Ababa to 
54.3% in 1990 (Mehret& Khodakevich,1990). Since then, the epidemic has expanded 
throughout the country both in rural and urban area and by the end of 1999, about 3 
million people were infected with the virus and made the population the third largest 
infected globally next to South Africa and India (UNAIDS 2000). 
The mode of transmission of the virus in Ethiopia is largely through heterosexual 
contact and mother-to child transmission with the highest prevalence of infection in the 
age group of 20-39.  Younger age females are also more affected and susceptible for 
HIV-1 subtype C virus than males (Abebe, 2001). According to AIDSCAP (2001), 
exacerbating factors for the rapid spread of HIV are: a) cyclical relocation of workers in 
hunt of employment, which expose them for extramarital sexual intercourse and multi-
partner sexual contacts, b) unrest and instability as a result of civil war, c) high 
prevalence of sexually transmitted diseases in high-risk susceptible groups, d) early 
sexual debut among youth, and e) huge unemployment rate in the country.  
In 1998, the peak HIV prevalence was in the age group 25–29 years, being 16.3% 
(Fontanet, 1998). For the age group 15-49, the prevalence had shown a decreasing 
fashion like 2.2% in 2005, 1.4% in 2010, and 1.1% in 2015 (UNAIDS, 2016).  In general, 
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the HIV prevalence levels for both men age 15-59 and women age 15-49  rise with age, 
but the peaking among women is in late 30s while for men is early 40s (EDHS, 2016).  
In 2011, the overall HIV prevalence was 1.5% with 1.9% among females and 
1.0% among males (EDHS, 2011). Five years back, the prevalence of HIV in women was 
2%, while for men age 15-49 was 1% (EDHS, 2005).  According to the Ministry of 
Health of Ethiopia, the Spectrum Model estimation of HIV prevalence for the year 2012 
showed 1.3% overall, 1.8% for females, and 0.9% for males (FMOH, 2012). The most 
recent 2016 Ethiopia EDHS reported, the prevalence of HIV in women increases with 
age, affecting 0.4% of women age 15-19 and 3.0% of women age 40-44, before declining 
to 1.9% among those age 45-49 (EDHS, 2016). 
In 1994, data from 11 urban blood bank centers showed that the prevalence of 
HIV varied from 5–20%, being 6.6% in Addis Ababa (National Blood Transfusion 
Service, Ethiopian Red Cross Society, personal communication, 1994). There is also 
prevalence difference in between urban and rural dwellers for both sexes. The prevalence 
of HIV for women was decreased from 7.7% in 2005 to 3.6 in 2016. Likewise, the 
prevalence for men was also decreased from 2.4 to 0.2% in 2005 and 2016, respectively 
(EDHS, 2005; EDHS, 2016). In the regions of Ethiopia, there is extensive prevalence 
difference, 6.6% in Gambella, 5.0% in Addis Ababa, and 0.7% in Southern Nations, 
Nationalities and Peoples’ region (SNNPR). 
High rates of HIV prevalence were soon detected along the main trading roads of 
the country, with HIV seroprevalence of 17% among commercial sex workers and 13% 
among truck drivers working along these roads in 1988. However, by 1998, HIV 
24 
 
 
 
prevalence among sex workers attending STD clinics had increased to 73% (Aklilu, 
2001).  Next to sex workers, long distance truck drivers are known to be at increased risk 
of HIV infection and their HIV prevalence in 1988 was 13% (Mehret, 1990).  
Unsolved Issues about Prevalence Changes in the Literature  
According to UNAIDS and WHO (2007), HIV prevalence is the proportion of 
people living with Human Immunodeficiency Virus (HIV), which is estimated to be 
about 0.5% of the world's population. To get the national HIV prevalence, a number of 
approaches are being used including: surveys, sentinel surveillance data in ANC, surveys 
of particular high-risk groups like sex workers, and using secondary data from national 
HIV/AIDS registries. Meanwhile, in the literatures reviewed,  even though there are a lot 
evidences showing that the prevalence of HIV in Ethiopia is in a decreasing fashion for 
different community groups, not adequate evidence obtained to show whether the HIV 
prevalence changes are valid in a statistical sense. In addition, there is little evidence to 
show where the epidemic is heading with different socio economic and demographic 
characteristics. Accordingly, this study has answered if the HIV prevalence changes in 
the country are valid in a statistical sense so as to show where progress is being made in 
controlling the epidemic, and where priority in the national HIV/AIDS control program 
should be made in resource constrained setting.  
Funding from Donors 
Even though a substantial development has been found in combating HIV/AIDS 
(UNAIDS, 2017), by allocating a significant amount of resources, the problem still 
creates very big challenges and remains an international emergency (United Nations 
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General Assembly, 2016). The continuing resource gap is one of the challenges. 
According to UNAIDS, even if US$19.1 billion was accessible from both international 
and domestic sources to address HIV in low- and middle-income countries in 2016 
(UNAIDS, 2017), US$26.2 billion will be wanted yearly by 2020 to end AIDS as a 
public health threat globally by 2030 (Izazola, Loures, & DeLay, 2016). 
In low and middle income countries, funding from donors represents the major 
share of the entire expenses for HIV; however, funding from all sources is very important 
to attain more progresses. In 2016, the donor funding in low- and middle-income 
countries for HIV decreased by $511 million (from US$7.5 billion in 2015 to US$7.0 
billion), which is a 7% decrement, and made it the lowest level disbursements since 2010.  
The reasons for the declining funding level were several including the one that accounts 
for the 50% decline - decreases in both bilateral and multilateral funding, exchange rate 
variations accounts for the 20% decline, malaria and tuberculosis accounts for 30%, the 
timing of U.S. contributions to the Global Fund to Fight AIDS, and due to U.S. law that 
limits its funding to one-third of total contributions to the Global Fund (Jen & Adam, 
2017). The 2016 decline is due to several factors: actual decreases in both bilateral and 
multilateral funding, accounting for an approximate net 50% of the decline; exchange 
rate fluctuations. 
HIV remains the second cause of mortality and morbidity in sub-Saharan Africa 
(Murray et al., 2012). One of the highest HIV prevalence in the world is in Sub-Saharan 
Africa, which is 5% and it alone makes up two-thirds of the worldwide HIV burden. 
About 5.7 million HIV-positive adults are living in South Africa. In 2003, PEPFAR 
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provided 60% of the bilateral assistance to 15 countries of Africa namely: Botswana, 
Cote d’Ivoire, Ethiopia, Guyana, Haiti, Kenya, Mozambique, Namibia, Nigeria, Rwanda, 
South Africa, Tanzania, Uganda, Vietnam, and Zambia.  In 2007, the adult prevalence in 
these countries were varied from 0.5 to 23.9% though courageous measures are being 
taken by most HIV-affected sub-Saharan Africa countries, generating adequate public 
resources for HIV prevention, care, and support activities couldn’t be possible; and 
hence, substantial international funding remains essential for years to come. On the other 
hand, increasing the government revenue-raising and mobilizing exceptional resources in 
relation to the epidemic control is becoming important in low and middle-income 
countries.  
According to UNAIDS (2014), the resource needed by 2015 for the HIV response 
and reducing the number of new infections and AIDS related deaths is about  US$22–24 
billion.  To significantly decrease the AIDS deaths by 90% and scale up the HIV 
responses by 2030, US$36 billion is estimated to be secured. So far, international 
financing serves are the substantial source of funding for HIV expenditure. However, 
because of enthusiastic economic growth predictions and augmented incomes from 
natural resources HIV funding from external donors is becoming flat-lining (Vassall et 
al., 2013); and hence, many international and provincial statements have called for 
governments to fund their own HIV responses (Buse & Martin, 2012; Galarraga et al., 
2013; Resch et al., 2015), which on the other hand inform donors to relocate their funds 
on countries that most need outside supports (Resch et al., 2015). 
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The U.S. and Global Fund are the largest donors of HIV programs in Africa 
accounting for 83% of the total funding. However, U.K., World Bank, and Sweden are 
among the five top contributors of the continent. According to Avert (2012), most of the 
HIV and AIDS funding is used for ART, HIV testing and counseling (HTC), Prevention 
of mothers - to-child transmission (PMTCT), condom use and distribution, voluntary 
male circumcision (VMMC), HIV education, and  HIV awareness.  
In the past decade, donors supported Anti-HIV/AIDS programs in Ethiopia has 
been fueling the rapid scale-up services with significant positive effects like dropping 
rates of new infections and prevention of millions deaths (UNAIDS 2011). Until 2011, 
Ethiopia has been supported from PEPFAR by more than $1.4 billion and by Global 
Fund with total disbursements of $1.16 billion, which made Ethiopia one of countries 
received more funding. The PEPFAR-Global Fund increased in 2010, but reduced almost 
by 50% as of 2012. Nowadays, there is a cliff in AIDS spending and the government of 
Ethiopia is in a free fall. Since 2013, Ethiopia has experienced a 79% HIV/AIDS budget 
reduction from PEPFAR because of HIV prevalence reduction and due to 
epidemiological trend changes. In only a year time, from 2012 to 2013, PEPFAR funding 
decreased by US$191 million.  
In 2008, more than 20% expenditure for other health programs was supported 
from AIDS funds; and almost 84% of it was also externally funded. Taking this all in to 
consideration, though the government of Ethiopia increased public spending, making 
significant new public funding to health was becoming unlikely because of the low 
revenue to GDP ratio and high inflation in the country. Accordingly, in spite of many 
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steps have been taken to improve the health of the people in the last decade, the people 
still suffer from different diseases and deaths. About 350,000 children die every year and 
majority (90%) of these deaths is due to easily preventable diseases viz., HIV/AIDS, 
pneumonia, malaria, diarrhea, and malnutrition. In addition, more than 90 % of new 
births are conducted in homes without skilled health professionals.   
Unsolved Problems about Funding from Donors in the Literature  
Even though there is a progress in relation to HIV prevalence in the country, the 
per capita income may not be adequate to run the started HIV activities effectively; and 
there is a fear to face serious health challenges if the external funders are not willing to 
continue supporting and able to sustain existing AIDS programs. The nearly 800,000 
people living with HIV, the second-leading cause of death in the country after respiratory 
infections, may get shortage of accessing ART. An extraction of donor financing, without 
a compensating domestic financing response, may damage the stability of care for those 
on ART, and creates huge opportunity costs by shifting fund from other programs run by 
domestic expenditures. Unexpectedly, some of the other programs run by domestic 
expenditures may also critical for the success of HIV responses. Accordingly, this study 
has tried to answer how the decreasing funding levels from the donors’ community is 
affecting the HIV prevalence and given recommendations on how the country finance its 
cost effective and efficient responses from domestic sources. 
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Type/Number of Services or Responses to Prevent and Control HIV/ADS and the 
Funding Levels from the Donors 
In 2016, 19.5 million people living with HIV were receiving antiretroviral 
treatment (ART) - up from 17million in June 2016 and 7.5 million in 2010. If this level of 
treatment scale up continues, it is estimated that the world will meet its global target of 
30 million people on treatment by 2020 (UNAIDS, 2017). According to WHO (2015), a 
number of vital performance indicators are being used to assess the attainment of ART 
programs. These performance indicators are: access, coverage of and equity for ART; 
timely initiation of ART for eligible; retention in care; and tracing of people with 
treatment failure and switching them to second-line regimens. In the past decade, these 
indicators were utilized by Ethiopia to monitor and evaluate the performance of its ART 
program (Assefa et al., 2010; Federal HIV/AIDS Prevention and Control Office, 2013). 
Ethiopia as the second populous country in Africa, the per capita income is $505 
and 31% of the people are living below the poverty line, which is $1.25/day; and hence, 
the country ranks 173 out of 187 countries in per capita Gross National Income (UN 
Human Development Index, 2014). However, the government of Ethiopia has shown 
strong commitment in responding to the HIV/AIDS epidemic since the first AIDS case 
was identified in 1984. The government has led a multi-sectoral response which engages 
government sectors, development partners, civil societies, and the private sector, for 
which the required governance structures, policy environment and systems for 
monitoring and evaluation were established and progressively improved based on lessons 
learnt from experiences. 
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The response has also required significant resources which have been invested 
from government, development partners and civil societies. According to WHO (2013), 
Ethiopia expends 3 to 5 percent of the Gross Domestic Product (GDP) on health while 
the foreign sources funding 30 to 50 percent; meanwhile, the annual per capita health 
spending is less than $25. In 2012, the total money spent for HIV/AIDS in Ethiopia was 
US$ 405 million; of which, US$ 350 million (86%) obtained from external sources, 
US$55 million (13%) from public income and US$ 680,000 (0.2%) from the private 
sectors. The proportion of spending the 2012 budget by regions shows that 43% was 
expended by federal/central government, 13% in Amhara, 13% Addis Ababa, 11% 
Oromia, 8% South Regions, and 22% for the remaining seven regions or towns (MOH, 
2014). 
In Ethiopia, the key sources for HIV/AIDS are public (mainly from federal level) 
and external sources (NHA, 2011). The MOH’s expenditure in 2012 for HIV/AIDS 
prevention and public health, outpatient and inpatient care, research, training, 
pharmaceuticals, and health administration was about 47 million. The second source of 
fund, mainstreaming fund, was contributed 3.5 million from sectoral ministries by saving 
2% of their budget.  In 2012, Ethiopia had external sources of fund, US$350 million, for 
HIV/AIDS prevention, care, and support programs from different governments including 
Canada, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Spain, Sweden, United 
Kingdom, and USA. In general, from external funds for HIV/AIDS, 59% was from 
government of USA, 30% from global fund, 7% from non-profit international 
foundations, and 4% from all other externals. Among the total funds obtained from 
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external sources for HIV/AIDS, 37% managed by the Government of Ethiopia, 60% by 
external agents, and 3% by private entities (UNAIDS, 2013). In relation to expenditure of 
money from all external sources by thematic area, HIV treatment, prevention, national 
system strengthening and Program coordination, and OVC support share the 30.9%, 
19.5%, 29.7%, and 6.8%, respectively (FHAPCO, 2012). On the other hand, 26%, 21%, 
26%, and 27% of the PEPFAR fund from 2010 to 2017 was used for prevention, care, 
treatment, and national system strengthening and governance, respectively.  
Nowadays, international assistance is essentially flat and some donor countries 
are reducing their funding (UNAIDS, 2012). Likewise, though the US federal funding for 
HIV has increased significantly over the course of the epidemic by $5.7 billion (or 20%) 
when comparing the FY2017 request (34 billion) to the FY 2011 enacted funding level 
(28.3 billion), funding to address HIV in Ethiopia from PEPFAR was declined since 
2010. In 2010, Ethiopia had $291million annual funding from PEPFAR while this 
amount decreased to $185 billion in 2012, $160 billion in 2013, $126 billion in 2014, and 
$100 million in 2018.  PEPFAR, the commitment of America, is supporting to save lives 
and realizing an AIDS-free generation globally. Funding from other donors including the 
United States was also either deteriorated or continued flat. The type of assistance from 
the donor community includes cash transfer, technical assistance, or commodities. 
Meanwhile, for all sort of assistance, US is the largest donor in the globe that covers 
about 65% of the HIV expenditures by donor governments. The second and third donors 
are U.K. and France cover 12.9% and 3.7% of the HIV expenses, respectively. 
 
32 
 
 
 
Unsolved Issues about Type/Number of Services and Funding Level 
According to HIV domestic priority index of UNAIDS (2010), for middle-income 
countries, to fund its own HIV responses and curb the HIV epidemic, their domestic 
spending should be increased sustainably; or the funds from international donors needs to 
be coordinated. Like any sub-Saharan Africa countries, Ethiopia is highly dependent on 
donor funding and increases worries about the sustainability of its national HIV response 
(Haacker, 2009) as funding scarcities will have a contrary impact to what has been 
achieved so far. In order to address the problem related to funding level decrement, 
vigorous financial tracking system should be in place to understand the funding trends 
and its relationship with type/number of services or responses to prevent and control 
HIV/ADS. Knowing the funding level and the type/number of services is critical so as to 
evaluate the spending patterns and to scale up high impact and effective interventions 
without interruptions of antiretroviral treatment (ART) and other amenities. 
Accordingly, this study examined if there is an association between the declining 
funding level and the change in HIV prevalence, and whether the funding shortfalls is 
potential to threaten the gains obtained so far to control the virus. The study has also 
recommended further studies to identify some specific high impact interventions to 
address some targeted groups with low funding level; and show the need of sustainable 
domestic investments to have robust response to the HIV epidemic. 
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Prevalence of HIV/AIDS with Different Socioeconomic and Demographic 
Characteristics 
Despite the fact that enormous people living with HIV are living in low- and 
middle- income countries, no county in the world is free from the impact of HIV/AIDS; 
and cure and vaccine are still distant hopes. One of the reasons that made the prevention 
and control measures of HIV much more complex is that factors exacerbating the 
transmission of virus from one person to another are more private, which can be 
socioeconomic, socio-cultural and/ or epidemiological (Bonnel, 2000). Knowing these 
determinant factors is very important so as to design effective responses.  
A long-held belief on HIV/AIDS is HIV epidemic is derived by poverty. 
UNAIDS also stated as poverty and underdevelopment aggravate HIV epidemic 
(UNAIDS, 2001). According to Fenton L. (2004), people practice high-risk behaviors if 
they are poor; and hence, reducing poverty is the only long term feasible solution to end 
the epidemic. As UNDP states, poverty comprises deficiency, controlled choices, and 
unsatisfied competences, and raises to interconnected features of well-being that 
influence the quality of life (UNDP, 2020). Poverty doesn’t essentially restrict to 
financial capital, enumerated, and reduced in monetary indices. While money is 
significant, lack of non-monetary resources also leads to sustains poverty (Shelton, 2005), 
and many people in Africa are in such poverty lacking assets and skills in addition to 
money. Accordingly, to have basic needs, they indulge into risky sexual behaviors to earn 
their breads. In a study done to see the prevalence of HIV in eight African countries 
(Ghana, Kenya, Lesotho, Burkina Faso, Malawi, Cameroon, Uganda, and the United 
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Republic of Tanzania) by wealth group, the study finding indicated as there is positive 
association between household economic status and prevalence (Mishra, 2007). 
According to Hallman K. (2005), poor people usually undertake particular risky practices 
like earlier sexual debut.  
As the result of insufficient financial and little assets poor households are 
marginalized socially, politically and excluded; and hence, these people are hard to reach 
for programs aimed to teach on sexual and other behaviors (Cohen, 1998); and incline to 
lack sufficient information. Poor people also have poor access to health services and 
nutrition; and can’t get treatment for STIs easily. According to Lurie (1995), health 
services impacts on HIV/AIDS epidemic is the non-treatment of STIs. They are 
biologically more vulnerable to HIV infection because of the weaken immune system 
(Stillwaggon, 2002).  
Gender discrimination empowers women and creates unfavorable environment 
fueling the evolution of HIV pandemic. If there is gender discrimination or inequality, 
women can’t negotiate for safe sexual intercourse even with HIV infected partner. The 
level of education is also one of the determinants of HIV infection. Though in sub-
Saharan Africa, at the beginning of the HIV epidemic, the infection infects and affects 
regardless of people’s educational status, less educated were highly susceptible and 
severely affected by the virus. Therefore, many study findings have shown that HIV 
infection goes hand in hand with higher socio-professional group, because they are better 
informed on preventive measures.  
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For economic reasons, people move from place to place and migrant workers 
placed themselves in isolated areas where they can’t get adequate information and meet 
their regular sexual partners for a long time, which expose them to unprotected sexual 
practices. Commercial sex work is also a common practice in such areas for economic 
motives. Governance or the attentions of governments that give due attention to 
HIV/AIDS influence the trend of the epidemic; because to invest in HIV/AIDS 
prevention and control activities, good governance that incited to invest enough in 
HIV/AIDS  and can make decision is pivotal. If a country has devastating economic 
situation and corrupted political environment, the epidemic is likely to scale up. 
Another factors demonstrated for having impact on HIV transmission include 
condom use and male circumcision. Condom protects the transmission of virus from a 
non-protected sexual intercourse between individuals. Male circumcision, prepuce 
removal for men, also showed positive impact on HIV transmission approximately 60% 
(WHO, 2015).  
Definitions 
Bilateral support: Bilateral aid represents flows from official (government) sources 
directly to official sources in the recipient country (UNAIDS, 2005). 
Demographic characteristics: Statistical data about the characteristics of a 
population, such as the age, gender and income of the people within the population 
(WHO, 2013) 
Demographic variables: Characteristics of the aggregate population that marketers 
use to segment the market, including age, ethnicity, income, education, gender, and race. 
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Education status: The status of a citizen of a country or state in relation to education 
or training defined in governmental law or legislation which could be school education, 
college education, university education, apprenticeship scheme, training course or 
another defined and appropriate status definition. 
HIV/AIDS prevalence: Refers to the percentage of people tested in each group who 
were found to be infected with HIV (UNAIDS, 2005). 
Household income: Household income is a measure of the combined incomes of all 
people sharing a particular household or place of residence. It includes every form of 
income, e.g., salaries and wages, retirement income, near cash government transfers like 
food stamps, and investment gains. 
Multilateral support: Represents core contributions from official (government) 
sources to multilateral agencies where it is then used to fund the multilateral agencies' 
own programs (UNAIDS, 2005). 
PEPFAR funding: The President's Emergency Plan for AIDS Relief is an 
Emergency Plan a five-year bilateral commitment by the United States Government to 
support HIV/AIDS prevention, care and treatment programs in developing countries 
(PEPFAR, 2016). 
Prevalence: Prevalence is a term used in epidemiology to describe the proportion of 
a population identified as having a certain condition (such as HIV). The prevalence figure 
is determined by comparing the number of people found to have the condition with the 
total number of people in that population group.  
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Proximate determinants conceptual framework: A framework provides guiding 
principles upon which socio-economic and socio-cultural variables affect HIV prevalence 
through biological behavioral factors. 
Single point estimate: An estimate of unknown population parameter by using 
sample data to calculate a single value. 
Socioeconomic: Relating to or involving a combination of social and economic 
factors. It is related to the differences between groups of people caused mainly by their 
financial situation (Shelton, 2005). 
The 90-90-90 Goal: The UNAIDS target to diagnose 90% of people living with 
HIV by 2020; put 90% of diagnosed people on antiretroviral treatment by 2020; and to 
suppress viral load of the 90% of people in treatment with fully by 2020(UNAIDS, 
2016). 
Assumptions 
One of the assumptions of this study was that the proximate determinants 
framework evaluated if the decrement of funding level from donor community was one 
of the risk factors of HIV spread and change in prevalence. Though the distribution and 
determinants of HIV infection comprised a lot of factors like socio-behavioral, 
epidemiological, and biomedical factors, the importance of the role of underlying 
socioeconomic and cultural determinants has been increasingly acknowledged (Aral& 
Holmes, 2006). Therefore, Key to the framework was the identification of a set of 
variables called proximate determinants that can be influenced by changes in contextual 
variables or by interventions and that has a direct effect on prevalence. In addition to this, 
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it was assumed that the findings on HIV prevalence from 2005 to 2016 from the Ethiopia 
Demographic and Health Survey (EDHS), which was implemented by the Central 
Statistical Agency (CSA), collected and analyzed the blood specimen as per protocol 
based on the anonymous linked protocol developed for The DHS Program and data were 
not manipulated or forged.  
Scope and Delimitations 
In this study, the major issue addressed was the trend of HIV prevalence and its 
association with funding levels from donors’ community. The reason for choosing this 
specific focus was to know the potential repercussion of the ongoing financial support 
reduction for HIV/AIDS response in the country (Garmaise, 2015) and the consequence it 
may create on the availability of ant-AIDS drugs and related prevention and care supports 
being given to millions of people. 
The scope/ boundary of this study was the inclusion of information of people, 
adult male and female population ages 15-59 years, participated in EDHS 2005/11 and 
2016 from the areas where the PEPFAR programs operates, tested for HIV, and had 
received HIV results. Meanwhile, this study didn’t cover the reason for prevalence 
changes over the year as well as the change of prevalence in areas where donors’ 
supports were not available from the beginning. Furthermore, as DHS doesn’t target 
children under 15 for HIV test, the trend analysis report in this study don’t have 
connection to this age group. The philosophical framework, proximate determinants, 
which has been used, also delimited the study as it determines the indirect determinant 
variables and delineates the population. Therefore, the result of this study could be 
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generalizable only to the PEPFAR program supported areas of the country and to the 
population groups from age 15-59 years. 
Significance of the Study 
The potential contribution of this study is examining the trend of HIV prevalence 
in the country as well as in each region from 2005 to 2016 vis-à-vis funding levels 
expended from donors’ community for the HIV prevention, care, and treatment services. 
In addition, the correlational analysis that was operated will inform the healthcare 
decision-makers whether there is an association between trend of HIV prevalence and 
funding levels; and if looking for sustainable financing initiatives is required. The 
findings could also deliver ideas if policy revision or formation is needed to target 
selected HIV/AIDS controlling activities in the national HIV/AIDS control program of 
Ethiopia in resource constrained settings secondary to the budget reduction or budget cut 
from the donors’ community; and contribute evidence for strategic advocacy for social 
change in terms of domestic resource mobilization.  
Summary 
The first section included a review of the problem statement that build up on 
previous research findings, the research questions and hypotheses, literature associated 
with Prevalence changes and trend of funding levels from donors’ along with unsolved 
and unresolved issues in the literature. Concise definitions of variables and assumptions 
that are critical to the meaningfulness of the study have been included sequentially. 
Boundaries of the study that identifying populations included and excluded are also 
illustrated. Furthermore, the application of the proximate-determinants as the theoretical 
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framework has been justified. Finally, brief summary of the methodology and rational for 
choosing the design have been discussed. The next section presents the research design 
and data collection.  
 
41 
 
 
 
Section 2: Research Design and Data Collection 
The purpose of this study was to examine HIV/AIDS funding from donors, and 
analyze if funding shortfalls threaten the gains made regarding HIV prevention strategies 
and whether there is an association between the prevalence of HIV/AIDS and declining 
donor funding in Ethiopia using the proximate-determinant framework. In this study, I 
reviewed and analyzed three national surveys, demographic and health surveys done 
between 2005 and 2016 with interval of 5 years, secondary data from two ANC clinics of 
public health facilities, and the expenditure analysis data from HIV/AIDS program 
implementing partners; and in this section, five main sub-sections have been described: 
namely, Research Design and Rationale, Secondary Data Analysis Methodology, 
Measurements for Variables, Data Analysis Plan, and Ethical consideration.  
Research Design and Rationale 
This is a quantitative study which used secondary data from EDHS, expenditure 
analysis data from HIV programs implementing partners, and health facility reports on 
HIV test results to examine the associations between the independent and dependent 
variables as well as HIV prevalence, funding, and trends. As there were more questions 
that the study needed to answer, multiple dependent variables were used for multiple 
measures. Accordingly, for research #1 (RQ1), the hypothesis of difference in prevalence 
among different regions was calculated, and Patterns were displayed by plotting HIV 
prevalence against years; for research #2 (RQ2), the dependent variable (the outcome) 
was funding level from donors whereas the independent variable (explanatory variable) 
was the HIV/AIDS prevalence; for research #3 (RQ3), the dependent variables were 
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Types/ number of services while the independent variables were the funding level from 
donors and HIV/AIDS prevalence; for research #4 (RQ4),the dependent variable was the 
HIV/AIDS prevalence while the independent variables were the socio 
economic/demographic characteristics including: age, sex, current marital status, 
educational status of sampled people, employment status, number of lifetime partners, 
place of living, wealth quintile, and age at first sexual intercourse. Reasons for studying 
this were to know how HIV prevention and controlling activities are affected by changes, 
which is declining, in funding from HIV programs donor communities and indicate what 
the national HIV/AIDS control program should give prior attention in Ethiopia while 
external budget support is declining. The rationale for using secondary data in this study 
to measure HIV prevalence and yield was that its analysis was a more convenient as the 
data were available, economical, and don’t need more time for data collection. 
Secondary Data Analysis Methodology 
Population  
As all women between15 and49 and all men between15 and 59 were the target 
population for the three DHS conducted in Ethiopia, this study targeted these groups of 
men and women along with their socioeconomic and demographic characteristics, HIV 
testing results, and types of HIV prevention services received. In addition, to analyze the 
trend of HIV/AIDS prevalence among 15 to 24yearsold pregnant women, ANC databases 
of two public health facilities in Ethiopia were used. Even though the principal objective 
of the EDHS project is to provide up-to-date estimates of key demographic and health 
indicators, it also collects data on knowledge and attitudes of people about HIV/AIDS 
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and evaluates potential exposure to the risk of HIV infection by exploring high risk 
behaviors and condom use.  
Sampling and Sampling Procedure 
The Ethiopia Population and Housing Census (PHC) results that were conducted 
by the Ethiopia Central Statistical Agency (CSA) are the sampling frames for each EDHS 
implemented since 2000. A complete list of enumeration areas comprises information 
about scene, type of residence (urban or rural), and estimated number of residential 
households were included in the frame. When the surveys were conducted, stratified 
sampling methods were used in two stages. Different sampling strata were yielded by 
dividing regions in to rural and urban.  Accordingly, samples of enumeration areas were 
selected independently in each stratum in two stages. Meanwhile, for this study, the 
sampling frames were the list of all adult population ages 15-59 years who participated in 
the past three surveys and who were tested for HIV and received their test results. By 
doing this, representativeness and external validity of the study were preserved.   
Inclusion Criteria for the Study 
For the purpose of this study, a sample of adult male and females between 15 and 
59 from the three DHS databases were enrolled. The study procedure had guideline for 
who can or cannot participate in the study. The inclusion criteria were age between 15 
and49 years for women and 15 and 59years for men who were tested for HIV and 
received HIV results.  
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Sample Size Calculation and Power Analysis  
 A minimum power of 0.80 and alpha (significance level) of 0.05 was used to 
obtain sample means in the critical region 5% of the time when the null hypothesis is 
true. A power of 80 %( or 0.8) indicates that if a survey is conducted repeatedly, 8 out of 
10 results will lead to statistically significant outcomes. The alpha or significance level 
(0.05) is the likelihood of making a type I error or rejecting the null hypothesis when it is 
true; and a probability of making a wrong decision (Faul et al., 2007; Trochim, 2006). 
This study enrolled the data of 1,067 sampled people from the 2005, 2011, and 
2016 EDHS (from Tigray, Amhara, Oromia, Afar, Somali, Benshangul, SNNPR, 
Gambella, Harari, Dire Dawa, and Addis Ababa regions) by taking in to consideration the 
total population studied by DHS, which was 26,753, and the 3% allowable error. The 
people sampled in three surveys were women between the ages of 15 and 49 and men 
between the ages of 15 and 59. For the 15 to 24-year-old pregnant women, data on HIV 
test results from ANC clinics of public health facilities in Ethiopia have been analyzed 
separately after each client record was selected using a convenience sampling method.  
Data Sources 
This study used multiple secondary data sources, mainly the three EDHS (2005, 
2011 and 2016) databases that had sampling frames from the Population and Housing 
Census conducted in 2007. The sampling frames comprise information about sites and 
place of residences of people that had equal chances to be selected for the surveys. In 
addition, the database of health facilities, FHAPCO, and records of HIV program 
implementing partners donated mainly by United State Aid for International 
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Development (USAID) and Centers for Disease Control and Prevention (CDC)Ethiopia 
have been used with each organization’s consent to review the trend of HIV prevalence 
and funding levels from donors.  
Measurements for Variables 
The EDHS survey codebook was used to detect both the dependent and 
independent variables of this study. For RQ2, funding levels from donors was dependent 
variable while HIV/AIDS prevalence was independent variable. Type and number of HIV 
services were dependent variables while funding levels from donors were independent 
variables for RQ3. For RQ4, HIV/AIDS prevalence was dependent variable while socio 
economic/demographic characteristics including: age, sex, current marital status, 
educational status of sampled people, employment status, number of lifetime partners, 
place of living, wealth quintile, and age at first sexual intercourse were independent 
variables. Likewise, to make the analysis plan and the selection of statistical tests simpler, 
each variable was leveled under Nominal, Ordinal, Interval, or Ratio. As the scale of 
the variable to be measured is potential to drastically affect the type of analytical 
techniques that can be used on the data, and what conclusions can be drawn from the 
data, all the necessary precautions were made.   
Data Analysis Plan 
Statistical Package for the Social Science (SPSS) Version 24 was used for 
statistical analysis of data. Using it, tabulated reports have been generated, distributions 
and trends have been plotted, and descriptive statistics and complex statistical analysis 
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were operated. To answer the research questions of this study, different analysis were 
operated as follows: 
RQ1: How has HIV prevalence changed in Ethiopia during the past 10 years? 
To know if there is a statistically significant change in prevalence of HIV, a trend 
analysis was made. Temporal patterns displayed by plotting yearly HIV prevalence 
against year. Accordingly, exponential trend lines were fitted to prevalence data for each 
regions of the country using the DHS 2005, DHS 2011, and DHS 2016 data to assess 
whether there have been changes in HIV prevalence over recent years; and to assess if 
these changes are statistically significant. The analysis was conducted separately for 
urban and rural sites in each region whenever data are available. For each region, the 
percentage change in fitted prevalence was calculated between the first and last year. The 
paired sample T-Test was performed for each five year (2005 against 2011; and 2011 
against 2016) as well as for the whole 10 years (2005 versus 2016) to assess whether 
differences in prevalence were statistically significant at p<0.05. In addition, to forecast 
how the prevalence will be changed until 2025, a time serious forecasting analysis was 
done.  
RQ2: How does the trend of HIV prevalence associate with funding from donors? 
In order to assess the relationship or association between the HIV prevalence and 
level of funding from donors’ community, perhaps there is a hypothesis that the funding 
level affects the accomplishment obtained in decreasing HIV prevalence; correlational 
analysis was computed to test this hypothesis.  For this analysis, data on the total funding 
level released for each region of the country in the past ten years and the annual 
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disbursements of PEPFAR investing to HIV prevention, care, and treatment services 
along with the HIV prevalence trends were correlated to identify the degree of correlation 
using Pearson Correlation of Coefficient (r). In addition, the bivariate plot for the two 
variables has been made to check the relationship. Once the correlation was computed, 
two-tailed testing with a significance level of 0.05 was also computed to check the 
significance level and to determine whether the observed correlation is a real one and not 
a chance occurrence.  
RQ3: What is the relationship between the type/number of services being 
provided to prevent and control HIV/ADS and funding from donors? 
To know if the type and number of HIV service are influenced by the funding 
level from the donors’ community, the relationship between services and their number of 
beneficiaries for adult treatment, adult care and support, pediatric care and support, ARV 
drug, HIV testing and counseling, and Orphan and Vulnerable children served (OVC) 
have been analyzed using Pearson's Chi-square test or Fisher's exact to see if there is a 
statistically significant difference among them. Accordingly, the analysis exemplified if 
the service types and beneficiary numbers are subjected to vary according to the level of 
funding. 
RQ4: What was the effect of different socioeconomic and demographic 
characteristics on the trend of HIV prevalence in the past 10 years? 
To know the impact of socioeconomic and demographic characteristics (age, sex, 
current marital status, educational status of sampled people, employment status, number 
of lifetime partners, place of living, wealth quintile, and age at first sexual intercourse, 
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etc.) on the prevalence of HIV to the different segment of the population, a multiple 
regression model was computed to efficiently estimate the measure of association 
between the dependent variable (prevalence) and independent variables (socioeconomic 
and demographic characteristics) while controlling confounding factors.  
A pair wise analysis was also employed among funding level and each 
explanatory variable to get the intercept, the regression coefficient for each of the 
predictor variable, the t-calculated, and p-value. In addition, the full regression model 
was operated to get the regression sum square (R2), and the condensed regression model 
was employed to find variable with most significant p-value. 
Ethical Consideration 
This study used databases from formerly conducted surveys (EDHS: 2005, 2011 
and 2016), Federal Ministry of Health (FMoH), and records of HIV program 
implementing partners donated mainly by USAID and CDC Ethiopia. Therefore, the 
issue of privacy or confidentiality was not applicable as this was already addressed by the 
principal data collectors. However, to use the data from each, data use agreements were 
obtained from both. 
Summary  
Section 2 mentioned the research design chosen to answer the research equations 
and the rationale for secondary data analysis methodology. The population enrolled in 
this study, and sampling and sampling procedures along with inclusion criteria were also 
illustrated well. Sample size calculation and power analysis have been addressed to get 
the right sample from demographic and health surveys. Last, the measurement of 
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variability, data analysis plan, and ethical considerations were discussed.  In Section 3, 
results and findings of the study in line with the four research questions will be presented. 
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Section 3: Presentation of the Results and Findings 
The purpose of this quantitative study was to examine the trend of HIV 
prevalence among Ethiopians and study funding levels from donors in different years for 
HIV prevention, care, and treatment; and analyzing if funding shortfalls threaten the 
gains made like low mortality rate due to AIDS because of the influence it may have on 
HIV prevention strategies. Accordingly, I examined changes in HIV prevalence among 
people who were sampled for DHS, funding levels, and type and number of services. 
Section 3 includes results of statistical analyses including a paired t-test, time series 
forecasting, Pearson correlation, Chi-square, Analysis of Variance (ANOVA), and 
multiple linear regression (MLR) on secondary data from DHS of Ethiopia. This section 
includes the results of the dependent sample t-test or paired sample t-test and time series 
forecasting (RQ1), Pearson correlation coefficient (RQ2), Chi-square test (RQ3), and 
multiple linear regression (MLR) (RQ4). At the end of this section, a summary statement 
has been added to conclude the results.  
Data Collection of Secondary Data Set 
The data source of this study, Ethiopian DHS for 2005, 2011, and 2016, are 
national household surveys studying nutrition, health, and population. So far, Ethiopia 
has conducted four series of DHS in 2000, 2005, 2011, and 2016, and the data from the 
latter three (2005, 2011, and 2016) have been considered to analyze key demographic and 
health indicators over time. All the surveys were implemented by the CSA at the request 
of the FMOH to back health policymakers and health program implementers in planning, 
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implementing, and evaluating programs and strategies to improve the quality of life of the 
population of Ethiopia.  
Descriptive Demographics of the Sample 
Table 1 shows descriptive analyses of the demographic characteristics of the 
1,067 people sampled from the three surveys. The variables included in this analysis are 
sex, age, place of residence, educational level, marital status, and region.  According to 
the results of this analysis, among the sampled individuals who were enrolled in the 
study, males (49.5%) and females (51.5%) were almost equally represented and this was 
similar in both surveys. Of the participants, 80% were between the ages of 15 and 39 for 
both sexes and 78.4% were from the rural part of Ethiopia. In terms of education level, 
41.8% have no education, 41.5% completed only primary school, and the remaining 
16.7% have secondary school and college diplomas. In relation to marital status, 61.2% 
were married and live together while 33.6% had never married. The number of widowed 
and divorced participants constituted the remaining 5.2%. As the sample was designed to 
represent the national population between the ages 15 to 49 years for women and ages 15 
to 59 years for men, the samples were taken from each region’s urban and rural areas and 
the two city administrations (Addis Ababa and Dire Dawa) proportionally in terms of the 
population that each region and city had. Hence, 35% enrolled people in this study were 
from Oromiya region followed by 23.9% from Amhara. The remaining were from the 
other seven regions and two city administrations.  
 
52 
 
 
 
Table 1 
Selected Background Characteristics of the Sampled People from Ethiopia DHS 2005,  
DHS 2011 and DHS 2016. 
 
 
(Table continued) 
 
 
 
 
  
Year 
Variable    DHS 2005 % EDHS2011 % EDHS2016 % 
 
Sex 
Female  527 49.4% 574 53.7% 549 51.4% 
Male 540 50.6% 493 46.3% 518 48.6% 
Total 1067 100% 1067 100% 1067 100% 
 
 
 
 
 
 
 
Sex 
15-19 241 22.6% 244 22.8% 222 21% 
20-24 184 17.2% 181 16.9% 171 16% 
25-29 158 14.8% 189 17.7% 183 17.2% 
30-34 139 13% 123 11.5% 149 13.9% 
35-39 123 11.5% 125 11.7% 123 11.5% 
40-44 102 9.5% 82 7.7% 96 8.90% 
45-49 75 7% 74 6.9% 76 7.1% 
50-54 45 4.2% 49 4.5% 25 2.3% 
55-59 0 0% 0 0% 22 2% 
Total 1067 100% 1067 100% 1067 100% 
Place of 
Residence 
Rural 898 84.1% 794 74.4% 819 86.2% 
Urban  169 15.9% 273 25.6% 248 13.8% 
Total 1067 100% 1067 100% 1067 100% 
 
 
Educational 
Level 
Secondary and 
above 
152 14.4% 167 15.6% 211 19.7% 
Primary School 371 34.7% 462 43.2% 497 46.5% 
No education 544 50.9% 438 41.2% 359 33.8% 
Total 1067 100% 1067 100% 1067 100% 
 
 
Marital 
Status 
Widow 50 4.6% 21 2% 0 0.0% 
Divorced 29 2.7% 53 4.9% 14 1.3% 
Married and 
live together 
630 59% 626 58.6% 704 65.9% 
Never Married 358 33.8% 367 34.5% 349 32.8% 
Total 1067 100% 1067 100% 1067 100% 
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Year 
Variable 
 
DHS 
2005 
% EDHS2011 % EDHS2016 % 
Region  Dire Dawa 30 2.81% 5 0.47% 8 0.75% 
 Addis Ababa 67 6.28% 59 5.53% 58 5.44% 
 Harari 9 0.84% 5 0.47% 3 0.28% 
 Gambella 63 5.90% 4 0.37% 3 0.28% 
 SNNPR 244 22.87% 203 19.03% 221 20.71% 
 Benishangul-
Gumuz 
14 1.31% 11 1.03% 11 1.03% 
 Somali 38 3.56% 21 1.97% 32 3.00% 
 Oromiya 334 31.30% 394 36.93% 393 36.83% 
 Amhara 228 21.37% 278 26.05% 260 24.37% 
 Afar 6 0.56% 17 1.59% 8 0.75% 
 Tigray 34 3.19% 70 6.56% 70 6.56% 
Total  1067 100% 1067 100% 1067 100% 
 
Study Results 
RQ1 
 RQ1: How has HIV prevalence changed in Ethiopia during the past 10years? 
 Statistical assumptions. In order to observe the differences between the two sets 
of values, before ART treatment officially initiated in the country (2005 prevalence) and 
10 years after treatment (2016 prevalence) and assure the quality of the results, a paired 
sample t-test was computed after evaluating the four main assumptions. According to 
Busing (2016), the four assumptions that need to be checked to drive a paired sample t-
test are that the dependent variable must be continuous, approximately normally 
distributed, and contain no outliers; in addition, observations are independent of one 
another. Hence, to operate this parametric procedure, all assumptions were met because 
the data for prevalence were numeric and continuous and could take any value within a 
range, the data were inspected for normality by using a histogram, which looked 
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approximately symmetrical and bell-shaped, and in the visual assessment using a box 
plot, there were no values that appear far away or outliers from the majority.  
 In addition to assessing the HIV prevalence changes in Ethiopia during the past 
10years, by extrapolating trends and patterns among the past HIV prevalence values, time 
series forecasting has been operated to predict future values or trends regarding the HIV 
epidemic using the Autoregressive Integrated Moving Average (ARIMA) (0, 1, 0) model 
without considering the effect of other variables. Likewise, to run the ARIMA modeling 
for forecasting time series, assumptions were checked and met. According to Huck 
(2004), time series analysis is based on the following assumptions: no acknowledged 
/assumed predictor variables, no seasonal forms, no one time irregularities, and there are 
dependable correlations between the variable to be forecast and other independent 
variables. 
 Trend analysis and paired sample t-test results. National HIV prevalence of 
Ethiopia was gradually decreasing over the 10-year study period (2005 – 2016). 
However, regional trends in terms of prevalence density among all ages have varied in all 
assessment periods. In 2016, the prevalence of HIV in Gambella (4.8%), Harari (2.4%), 
Addis Ababa (3.4%), and Dire Dawa (4%) regions are far higher than the national 
prevalence (0.9%) and the global cutoff point for generalized epidemic declarations. 
Conversely, yearly HIV prevalence rates for Oromia (0.7%), Somali (0.01%), 
Benishangul Gumuz (1%), and SNNPR (0.4) were less than the average annual national 
HIV prevalence, as shown in Figure 1.  
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Figure 2.HIV prevalence by region of Ethiopia, 2005–2016. 
 
The observed decrement in prevalence during the 10 years intervention time in 
Gambella was only about 18%. For about seven years from 2005, the prevalence was 
increasing steadily, but later after 2012, it starts decline even though that prevalence is 
still more than five folds higher than the national prevalence. In 2016, Gamblella was the 
first region with highest HIV prevalence. 
 
 
 
Figure 3.The trend of national HIV prevalence of Ethiopia, 2005–2016. 
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Figure 4.HIV prevalence among all age groups for Gambella region, 2005–2016. 
The prevalence of HIV in SNNPR at 2016 was worse than the prevalence that the 
region had ten years before 2016. In 2005, it was 0.2% while it increased to 0.9% in 
2011; and gradually decreased to 0.4% in 2016. Among the 9 regions and 2 city 
administrations in Ethiopia, the two regions that have higher prevalence of HIV in 2016 
comparing their own prevalence data of 2005 are SNNPR and Benshangul Gumuz.  
Benshangul Gumuz had prevalence of 0.5% in 2005 and 1% in 2016, which was doubled 
though many prevention and control programs were run in the regions for a decade.  
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Figure 5.HIV prevalence among all age groups for SNNPR, 2005–2016. 
The changes in prevalence among the national urban and national rural dwellers of 
Ethiopians seem following the same decreasing fashion. There is a 53 % and a 57 % 
decrement of prevalence in urban and rural areas, respectively. However, at 2016, the 
HIV prevalence in urban areas was seven times higher than the rural prevalence.      
 
Figure 6.HIV prevalence among all age groups for urban and rural dwellers, 2005–2016. 
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Figure 7.HIV prevalence by age, EDHS2005, EDHS 2011, and EDHS2016. 
A paired t-test was used to compare the changes in HIV prevalence rates between 
the nine regions and two city administrations before and after the intervention of HIV 
prevention, care and support activities. Running a paired t-test allowed to see the effect of 
interventions in spite of effects unique to certain regions. Table 2 shows for the statistical 
analysis output obtained from a paired sample t-test, which represents regions’ beginning 
prevalence (2005) and their 2016 prevalence.  
Table 2 
Paired Sample T-Test among the HIV Prevalence in 2005, 2011, and 2016 
  Paired Differences 
t df 
Sig. 
(2-
tailed
) Mean 
Std. 
Deviat
ion 
Std. 
Error 
Mea
n 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 Prevalence  in 2005 
to 2016 
 
.71727 
 
.61130 
 
.18431 
 
.30660 
 
1.12795 
 
3.892 
 
10 
.003 
Pair 1 Prevalence  in 2005 
to  2011 
 
.10000 
 
.65422 
 
.19725 
 
-.53951 
 
.33951 
 
-.507 
 
10 
.623 
Pair 1 Prevalence in 2011 
to  2016 
 
.81727 
 
.59083 
 
.17814 
 
.42035 
 
1.21420 
 
4.588 
 
10 
.001 
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The results from the outputs (Table 2) shows that the prevalence in 2005 (M = 
.10, SD = .65) and the prevalence in 2016 (M = .71, SD = .61), demonstrated a significant 
difference in for the general ten years national HIV prevalence (t (10) = 3.89, p = .003). 
Likewise, the prevalence in the first and second five years was found to be different. In 
addition, the t-value of the three analyses (3.89, -.51, and 4.59) shows the size of the 
difference between the mean HIV prevalence rates of the three periods being compared. 
Accordingly, the large t-value with in 2011 and 2016 indicates a correspondingly large 
difference between the mean HIV prevalence rates in those years. In addition, the 
analysis from the records of the 1000 pregnant women 15 to 24- Years-Old attending two 
ANC clinics of public health facilities in Bishoftu and Addis Ababa from January 2006 to 
June 2016 depicted as the HIV among pregnant women has notable decline (Figure 9). 
 
 
 
Figure 8.HIV prevalence by sex in 2005, 2011, and 2016. 
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Figure 9.HIV among pregnant women attending ANC by year. 
Time series forecasting result. In this time series analysis that was conducted for 
the national, urban, and rural HIV prevalence of Ethiopia between the year 2017 and 
2025, the forecasting demonstrated that there is likelihood for the HIV prevalence trend 
continue decreasing beyond the year 2017 both for national, urban, and rural Ethiopia.  
The HIV Prevalence will decline from 2.7% (95% CI 2.9 – 2.4%) in 2017 to 0.7% (95% 
CI 1.5 – 0.0%) in 2025, 0.4% (95% CI 0.5 – 0.3%) in 2017 to 0.2% (95% CI 0.4 – 0.1%) 
in 2025, and 0.9% (95% CI 1.0 – 0.7%) in 2017 to 0.5% (95% CI 1.0 – 0.1%) in 2025 for 
urban, rural, and national, respectively.  
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Figure 10. Time series forecasting of national, urban, and rural HIV prevalence rates 
using ARIMA model 
 
Table 3 
Forecasted HIV Prevalence Value for the Period between 2017 and 2025. 
Forecast 
Model 2017 2018 2019 2020 2021 2022 2023 2024 2025 
Urban HIV Prevalence-
Model_1 
Forecast 2.7 2.4 2.2 1.9 1.7 1.5 1.2 1.0 .7 
UCL 2.9 2.7 2.6 2.4 2.2 2.0 1.9 1.7 1.5 
LCL 2.4 2.1 1.8 1.5 1.2 .9 .6 .3 .0 
Rural HIV Prevalence- 
Model_2 
Forecast .4 .3 .3 .3 .3 .2 .2 .2 .2 
UCL .5 .4 .5 .5 .4 .4 .4 .4 .4 
LCL .3 .2 .2 .1 .1 .0 .0 -.1 -.1 
National HIV 
Prevalence-Model_3 
Forecast .9 .8 .8 .8 .7 .7 .6 .6 .5 
UCL 1.0 1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.0 
LCL .7 .7 .5 .5 .4 .3 .2 .1 .1 
 
 
Hypothesis test result. The hypothesis being tested here is whether the HIV 
prevalence in the ten years, 2005 – 2016, are the same or statistically different. In this t-
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test, the prevalence of the same regions was used to see the change in prevalence between 
2005 and 2010, 2005 and 2016, and 2010 and 2016 separately. As the p-value helps to 
decide whether to accept or reject the null hypothesis, it was imperative to compare the p-
values at the significance level of 0.05. The 95 percent confidence interval of the 
difference provides an estimate of the boundaries between which the true mean difference 
lies in 95 percent of all possible random samples of regions participating in this study.  
As illustrated in Table 2, the t-statistic was obtained by dividing the mean 
difference by its standard error to give the t-values of 3.89, -.51, and 4.59. The Sig. (2- 
tailed) column for the period from 2005 to 2010 shows that the probability of obtaining a 
t statistic whose absolute value is equal to or greater than the obtained t statistic is .62. 
Since the significance value for the difference in HIV prevalence rates between those 
years is greater than 0.05 (p =.623), it can be concluded that the average difference in 
HIV prevalence rate of -.100 is due to chance variation. This means, the change in 
prevalence of HIV in the first five years (2005 – 2010) was not statistically significant. 
However, from 2011 to 2016, there was a gradual decrease in the HIV prevalence rate 
and this change was statistical significant (t [10] = 4.59, p = .001), which led to reject the 
null hypothesis. 
Answers to RQ1.The results of the hypothesis tests, trend analyses and Paired 
Sample T –Test, showed as the national HIV prevalence change in Ethiopia during the 
past ten years was statistically significant because there was a significant difference in 
scores for DHS 2005 (M = .10, SD = .65) and DHS 2016 (M = .72, SD = .61) conditions; 
t (10) = 3.892, p = 0.003.  However, while comparing the changes in prevalence between 
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the first five years (2005 – 2011) and the second five years (2011 – 2016), the HIV 
prevalence change from 2005 to 2011 was not statistically significant with t (10) = -.51, p 
= .623.  
RQ2 
RQ2: How does the trend of HIV prevalence associate with funding from donors? 
Statistical assumptions. Prior to conducting correlation analysis between the 
national HIV prevalence and the annual budget, the two variables have been plotted to 
visually inspect the linear relationship they have and the data follows. The bivariate plot 
below (Figure 6) shows how the two variables are related or changed together without 
addressing the question of causality. According to Busing FM (2016), to compute the 
Pearson’s Coefficient, the data set should be normally distributed, a scatter plot should 
show a linear relationship among data, no outliers, and variables should be continuous.  
Accordingly, in this analysis all the assumptions were met. 
The Pearson correlation result. Pearson correlation product – moment 
correlations, or r, has been calculated for the national and some specific regions’ funding 
level and prevalence to measure the linear relationship between the donors’ financial 
support to fight HIV/AIDS and the HIV prevalence trends. Accordingly, the output 
(Table 4) gives a correlation matrix for the two correlations and the correlation 
coefficient show as there is a positive correlation between funding level from donors’ 
community for HIV prevention, care, and support, and national HIV prevalence. This 
positive correlation coefficient (.635) indicates that there is a statistical significant (p = 
.027) linear relationship between these two variables such that the less prevalence level 
the country has nationally, the smaller the funding level from donors is. This analysis was 
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also supported by the Bivariate plot (Figure 6) with regression line and R2 = 0.52, which 
tells 52% of the variability in national prevalence rate of HIV is accounted for budget 
level from donors like PEPFAR. However, in a separate analysis that has been computed 
for all regions to see whether the allocation of funds that obtained from donors for HIV 
prevention, care, and support have a similar positive correlation with their prevalence or 
not, the result in two regions shows no relationship between the prevalence of HIV and 
the budget obtained from donors. The Pearson Correlation and Sig. (2-tailed) for Tigray 
(r = .375, p =.229), and Gambella (r = .281, p =.376). This indicates the investment to 
HIV prevention, care, and treatment along with the HIV prevalence trends hasn’t been 
correlated in those two regions.  
 
 
Figure 11. Bivariate plot showing the relationship between the changes in the national 
prevalence rate and funding level from 2005 to 2016. 
 
 
 
65 
 
 
 
Table 4 
Correlation between Funding levels from Donors and the Trend of HIV Prevalence. 
Correlations 
 
National Funding 
Level from 
Donors National Prevalence 
National Funding Level from 
Donors 
Pearson Correlation 1 .635* 
Sig. (2-tailed)  .027 
N 10 10 
National Prevalence Pearson Correlation .635* 1 
Sig. (2-tailed) .027  
N 10 10 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Hypothesis test result. There was a statistically significant (r (10) = .635*, p = 
.027) association between the two variables; and hence, the null hypothesis stated - the 
level of donors’ financial support to fight HIV/AIDS has no relationship with the 
epidemiological or national HIV prevalence trends – will be now rejected and the 
alternative hypothesis accepted.  
 
 
 
 
Figure 12.Sources of funds for HIV/AIDS (2005 - 2016). 
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Answers to RQ2. As correlation measures the linear relationship between two 
variables, the correlation coefficient between HIV prevalence and funding levels from 
donors’ community has a value of .635* (Table 4) indicates that the association between 
the two variables is statistically significant (p = .027) and have a positive linear 
relationship such that the less prevalence the country has, the smaller that country’s 
funding level from donors community is.   
RQ3 
RQ3: What is the relationship between the type and number of services or 
responses to prevent and control HIV/ADS and funding from donors? 
Statistical assumptions. This research question was analyzed by using crosstabs 
and Pearson’s chi-square. The assumptions to apply a chi-square test include (a) datasets 
are large enough, (b) not be used on correlated data/ independence, (c) nominal or ordinal 
categories, and (d) more than 80% of the contingency cells having expected values 
greater than five (Busing, Weaver, &Dubois , 2015), have been checked for all and 
confirmed for meeting the assumptions.  
The Chi-square test result. The frequency cross tabulated result (Table 5) 
indicates that there is a highly significant relationship between the different HIV 
prevention, care, and support services and funding level. The sample included the 
information of 1067 people served in different years, 37.7% who were served for adult 
treatment, 64.7% who were provided adult care and support, 12.3% who obtained 
pediatric care and support, 37.5% who were put on ARV drugs, and 59.4% who were 
counseled and tested for HIV. The budget allotted for different service areas was also 
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different in different years (Figure 7 and 8). Accordingly, the Pearson Chi-Square Values 
for all service areas indicate as there is a highly significant relationship between: funding 
level and adult treatment, χ2 (2, N = 1067) = 1425.7, p< .001, funding level and adult 
care and support, χ2 (2, N = 1067) = 268.7, p< .001, funding level and pediatrics care and 
support, χ2 (2, N = 1067) = 12.5, p = .002, funding level and ARV drug, χ2 (2, N = 1067) 
= 38.5, p< .001, and funding level and HIV testing and counseling, χ2 (2, N = 1067) = 
181.2, p< .001.  
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Table 5 
Type and Number of HIV Services and Funding Levels for 2005, 2011, and 2016. 
  Funding Level for each year Total Pearson 
Chi-
Square 
Value 
df Asymptotic 
Significance 
(2-sided 50,000,001-
100,000,000 
100,000,001 -
150,000,000 
250,000,001-
300,000,000 
 
 
 
Adult 
Treatment 
NO Count 1067 224 702 1993 1425.776a 0 0.000 
% within Funding 
Level for each year 
100.00% 21.00% 65.80% 62.3% 
YES Count 0 843 365 1208 
% within Funding 
Level for each year 
0.00% 79.00% 34.20% 37.7% 
Total Count 1067 1067 1067 3201 
% within Funding 
Level for each year 
100.00% 100.00% 100.00% 100% 
 
 
 
Adult Care 
and 
Support 
No Count 577 225 328 1130 268.795a 2 0.000 
% within Funding 
Level for each year 
54.08% 21.09% 30.74% 35.3% 
Yes Count 490 842 739 2071 
% within Funding 
Level for each year 
45.92% 78.91% 69.26% 64.7% 
Total Count 1067 1067 1067 3201 
% within Funding 
Level for each year 
100.00% 100.00% 100.00% 100% 
 
 
 
Pediatric 
Care and 
Support 
NO Count 946 906 957 2809 12.564a 2 0.002 
% within Funding 
Level for each year 
88.66% 84.91% 89.69% 87.7% 
YES Count 121 161 110 392 
% within Funding 
Level for each year 
11.34% 15.09% 10.31% 12.2% 
Total Count 1067 1067 1067 3201 
% within Funding 
Level for each year 
100.00% 100.00% 100.00% 100% 
 
 
 
ARV 
Drugs 
NO Count 607 651 743 2001 38.521a 2 0.000 
% within Funding 
Level for each year 
56.89% 61.01% 69.63% 62.5% 
YES Count 460 416 324 1200 
% within Funding 
Level for each year 
43.11% 38.99% 30.37% 37.4% 
Total Count 1067 1067 1067 3201 
% within Funding 
Level for each year 
100.00% 100.00% 100.00% 100% 
 
 
HIV 
Testing 
and 
Counseling 
NO Count 267 567 467 1301 181.294a 2 0.000 
% within Funding 
Level for each year 
25.02% 53.14% 43.77% 40.6% 
YES Count 800 500 600 1900 
% within Funding 
Level for each year 
74.98% 46.86% 56.23% 59.4% 
Total Count 1067 1067 1067 3201 
% within Funding 
Level for each year 
100.00% 100.00% 100.00% 100% 
 
Hypothesis test results. As there was a statistically significant (p < 0.05) 
association between the number and type of HIV related services and funding level, null 
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hypotheses, which states the type and number of services being provided to prevent and 
control HIV/ADS in Ethiopia have no relationship with the yearly funding levels from 
the donor community, will be rejected secondary to comparing the p-value, which is less 
than the significance level (0.05). In addition, the population proportions in each category 
are not consistent with the specified values in each category; and hence, the observed 
values of samples in relation to service areas given in different years with different 
funding levels and expected values from the specified distribution are statistically 
different.   
 
 
Figure 13.  The budget amount allotted for different service areas in different years. 
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Figure 14. The proportion of budget utilized in different service areas from 2005 – 2016 
 
Answers to RQ3.Results of the hypothesis tests using a chi-square test of 
independence showed a significant associations and meaningful effect of funding level on 
each of the dependent selected variable. The large chi-square statistics and small 
significant level (P< .005) for each indicates that it is very unlikely that these variables 
are independent of each other. Hence, funding level matters who gets what services and 
the frequency.   
RQ4 
RQ4: What was the effect of different socioeconomic and demographic 
characteristics on the trend of HIV prevalence in the past 10years? 
Statistical assumptions. To carry out this multiple regression, all the required 
assumptions have been checked to make sure that the data used could actually be 
analyzed using multiple regression. Some of the assumptions checked were whether the 
dependent variable is measurable in a continuous scale, if there are two or more 
independent variables, if there are no significant outliers, and if there is a linear 
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relationship between the outcome variable and the independent, which was checked by 
using a scatter plot. As most of the multiple regression assumptions were met, this 
investigation has been computed to see the variables that are good predictors of the 
current HIV status.  
The regression test result. To investigate the effect of predictor variables, age at 
first sexual intercourse, place of living, number of lifetime partners, educational status, 
current marital status, sex, employment (in the last 12 months), wealth quintile, and age 
at the time of study, on an outcome variable – HIV Positive Status, a multiple linear 
regression, an extension of a linear regression, was computed using SPSS statistics. 
Consequently, a significant regression equation was found (F (9, 1056) = 12.639, p < 
.001) with an R2 of = .375. The R, R-Square (R2), adjusted R2, and the standard error of 
the estimate were used to determine how well the regression model fit the data. Hence, 
the R – value (the "R" Column of Table 6) is .612, which represents the multiple 
correlation coefficient between the predictors and the dependent variable and indicating a 
good degree of association with fair quality of prediction.  The R2 value (the "R Square" 
column of Table 6) is .375; and this represents the coefficient of determination that is the 
proportion of variance in the dependent variable, HIV prevalence, can be explained by 
the independent variable. This means, according to this analysis the dependent variables 
explained 37.5% of the variability of the dependent variable, HIV status, which of course 
not too much. 
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Table 6 
Model Summary Table for Predictors 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .612a .375 .590 4.112 
 
Table 7  
F-ratio in the ANOVA Table 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 1.438 9 .160 12.639 .000b 
Residual 13.351 1056 .013   
Total 14.789 1065    
a. Dependent Variable: HIV Status 
b. Predictors: (Constant), Age at first sexual intercourse, PLACE OF LIVING, Number of lifetime partners, Educational 
Status of sampled People , Current marital status, Sex of Sampled people, Employment (last 12 months), Wealth quintile, 
Age of sampled people 
 
Table 8  
Information about the Effect of Individual Predictor Values 
Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence 
Interval for B 
B 
Std. 
Error Beta 
Lower 
Bound 
Upper 
Bound 
1 (Constant) -.012 .027  -.443 .658 -.064 .041 
Age of sampled people -.005 .009 -.038 -.586 .558 -.022 .012 
Sex of Sampled people .007 .011 .029 .613 .540 -.015 .029 
Current marital status .065 .009 .344 6.966 .000 .047 .084 
Educational Status of sampled 
People .009 .006 .067 1.511 .131 -.003 .021 
Employment (last 12 months) .038 .013 .148 2.951 .003 .013 .063 
Number of lifetime partners .015 .006 .087 2.534 .011 .003 .026 
PLACE OF LIVING -.087 .011 -.348 -7.765 .000 -.109 -.065 
Wealth quintile 5.886E-5 .005 .001 .012 .991 -.010 .010 
Age at first sexual intercourse -.018 .007 -.186 -2.626 .009 -.032 -.005 
a. Dependent Variable: HIV Status 
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Table 8 provided the necessary information to predict HIV status from 
socioeconomic and demographic characteristics, as well as determine whether HIV status 
contributes statistically significantly to the model by looking at the Sig. column. The 
unstandardized coefficients indicates as the value of dependent variable or the likelihood 
of getting HIV increases based on the increase in each unit changes in predictor value of 
current marital status, employment (last 12 months), number of lifetime partners, place of 
living, and age at first sexual intercourse. Meanwhile, the Beta coefficient for current 
marital status (whether never married, or married and living together, or divorced, or 
widowed) is found to be the better predictor for the current HIV status (β = .344, p < 
.001). The significant test for each of the independent variables in the model was also 
indicated under p-value.  The p-value for the variables: current marital status (p = .047), 
employment in the last 12 months (p = .013), number of lifetime partners (p = .003), 
place of living (p < .001), and age at first sexual intercourse (p = .009) indicate strong 
evidence against the null hypothesis. In addition, the coefficient for current marital status 
is .344.  So, for every unit increase in marital status, a 0.34 unit increase in prevalence is 
predicted, holding all the variables constant. Likewise, for every unit increase in number 
of lifetime partners, a .087 unit increase in prevalence is also predicted.  
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Figure 15.HIV prevalence by wealth quintile. 
Hypothesis test result. The F-ratio in the ANOVA (Table 7) shows the overall 
variance accounted for in the model and the overall regression model fit to the data and 
some of the independent variables statistically significantly predict the dependent 
variable, (F (9, 1056) = 12.639, p< .001), indicating the null hypothesis, that states The 
HIV prevalence, in the past ten years, show similar trends to all Socioeconomic and 
Demographic Characteristics is rejected. The remaining variables, age (p = .558), sex (p 
= .540), educational status (p = .131), and wealth or economic status (p =.991) were not 
statistically significantly to the predictors.  
Answers to RQ4.As per the multiple linear regression model summary and overall 
fit statistics, the adjusted R² of the model is .590 with the R² = .375. This means that the 
linear regression indicated 5 of the 9 predictors explain 37.5% of the variance, which 
shows how well the regression equation fits the data to predict the dependent variable 
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significantly. Hence, the prevalence of HIV was not the same for all socioeconomic and 
demographic characteristics in the past 10years, 2005 – 2016. 
Summary 
Section 3 illustrated major findings of the four research questions of this study. In 
this section, the purpose of using quantitative study, the data sources, the result of 
descriptive analyses to the demographic characteristics of sampled people, statistical 
assumptions for each statistical tests, test results, and answers to research questions have 
included. This doctoral study examined the data collected for the three (2005, 2011, and 
2016) Demographic and Health Surveys conducted in Ethiopia. The target populations 
for these surveys were all women ages 15 to 49 years and all men ages 15 to 59 years. 
The result of this study has demonstrated as the national HIV prevalence changed 
in the country during the past ten years was statistically significant because there was a 
difference in scores for prevalence in 2005 (M = .65, SD = .61) and the prevalence in 
2016 (M = .71, SD = .61) conditions; (t (10) = 3.89, p = .003).  The national trend of HIV 
prevalence was also found associated with funding levels from donors’ community, r = 
.635, p .027, and funding level matters who gets what service areas, P< .005. Last, the 
result depicted as the prevalence of HIV in the study periods was not the same for all 
socioeconomic and demographic characteristics, F (9, 1056) = 12.639, p = .00001. 
In the next chapter, chapter 4, the detail interpretation and analysis will be 
presented along with its application to Professional Practice and Implications for Social 
Change. Likewise, section 4 will encompass comparison of findings to literature, 
limitations, recommendation, and conclusions that are pertinent to this doctoral study.  
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Section 4: Application to Professional Practice and Implications for Social Change 
The purpose of this quantitative secondary data analysis was to examine the 
trends of HIV prevalence in Ethiopia from 2005 to 2016 and funding levels from donors 
for HIV prevention, care, and support services during those years. In addition, the study 
explored if funding from donors is a proximate determinant for prevalence change, 
funding shortfalls threaten the gains like reduction of mortality rate due to HIV/AIDS, 
and there is an association between declining funding levels and the change in prevalence 
of HIV/AIDS. The reasons for conducting this study were to understand how HIV 
prevalence is being changed in Ethiopia, how the change in HIV prevalence is associated 
with funding levels from donors, how the change in funding level influence the type and 
number of services, and the effect of different socioeconomic and demographic 
characteristics on the trend of HIV prevalence. 
This study illustrated that the national HIV prevalence change in Ethiopia during 
the time from 2005 to 2016 was statistically significant (t (10) = 3.892, p = 0.003).HIV 
prevalence and funding levels from donors have a linear relationship (r (10) = .635, p = 
.027), and there are significant associations and a meaningful effect of funding level on 
number and type of services (P< .005), and the regression test computed to investigate 
the effect of predictor variables showed that current marital status, employment 
status(last 12 months), number of lifetime partners, place of living, and age of first 
instance of sexual intercourse are better predictors for current HIV status (β = .344, p< 
.001). 
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Interpretation of the Findings 
My analyses of the DHS and facility-based data to answer the four research 
questions indicated significant relationships between the trend of HIV prevalence, 
funding level, and the number and type of services. In the following subsection, I 
compared findings to the literatures and the proximate determinant framework. The 
comparison follows the research questions’ series.  
Comparison of Prevalence Findings with Literature  
National prevalence. According to Tadele, Abebaw, and Abdulsemed(2016), 
even though there were 160,000 new HIV infections annually in Ethiopia, this number 
gradually declined by 81% in 2016. The number of newly infected people has also 
declined by 0.1352 per 1000 people since 1990 and reached 0.33 per 1000 among all ages 
in 2016. Kendall and Danel (2014) said that the burden of HIV in Ethiopia shows a 
decreasing trend because of the substantial advances that have been made to increase 
access to services, reduce stigma and discrimination, increase social support, and 
mobilize communities. Likewise, the findings of this study confirm that HIV prevalence 
in Ethiopia declined from 1.4% in 2005 to 0.9% in 2016 for all groups and this change 
was valid in a statistical sense. However, between 2006 and2011, the prevalence was 
unchanged despite many prevention and control measures were undertaken.  
Regional prevalence. UNAIDS (2013) showed Ethiopia has a generalized and 
heterogeneous type of epidemic with regional variations. EDHS (2011) had also 
illustrated variations in HIV prevalence among regions ranges from 0.9%, 1%, 5.2%, to 
6.5% for SNNPR, Oromiya, Addis Ababa, and Gambella regions, respectively. This 
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variation was also observed in this analysis. Gambella had the highest prevalence in the 
past 10years (6% in 2005, 6.5% in 2011, and 4.8% in2016) followed by Addis Ababa 
(4.7% in2005, 5.2% in2011, and 3.4 % in2016). There were also some regions that had 
lower HIV prevalence before ten years and in 2016 their HIV prevalence increased 
noticeably. Regions with the lowest prevalence at the beginning and increased later 
include SNNPR (0.2% in 2005 and 0.4% in 2016) and Benshangul Gumuz (0.5% in 2005 
and 1% in 2016).  
HIV Prevalence by Urban and Rural Areas of Ethiopia. Ethiopia had a 
prevalence reduction of 55%in between 2000 to 2008, p<0.00. However, at the beginning 
of 2005, the difference between urban and rural HIV prevalence had a large width 
ranging from 0.7% for rural areas to 5.7% for urban areas, but this variation reached 
0.6% in 2011 and 0.4% in 2016 for rural areas and 4.2% in 2011 and 2.9% in 2016 for 
urban areas. In this study, 78.4% of sampled people enrolled were from rural parts of 
Ethiopia while 21.6% were from urban areas. The reduction in prevalence in the 
mentioned period was also observed in many African countries by 25% both in urban and 
rural areas, which was a statistically significant change. While Ethiopia had a prevalence 
reduction of 55% during 2000 to 2008, Kenya had a reduction of60% in rural and urban 
areas (p<0.01). Likewise, studies show that HIV prevalence had exhibited a dropping 
trend in greater than 80% of African countries both in urban and rural areas.  
Prevalence by sex and age group. In many countries, there is evidence 
indicating that HIV prevalence among young people is declining due to changes in risky 
sexual behavior including early sexual debut, multiple sexual partners, and unprotected 
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sexual intercourse. The largest decrease (42%) has been observed in African American 
women since 2005; and in the time from 2011 to 2016, in US, there was a 25% decline in 
prevalence while the prevalence for men has declined by 11% since 2005 (CDC, 2016). 
Similarly, the decreasing prevalence trend has also been observed in Ethiopia both for 
women and men between the ages of 15 and 49. In the period between 2005 and2016, 
prevalence declined for women (statistically significant at p<0.05) and was higher for 
men (1.9% versus 0.9% in 2005, 1.9% versus 1.0% in 2011, and 1.9% versus 0.6% in 
2016). As age of women increases, HIV prevalence also increased from 0.4% to 3% for 
the 15-19 and 40-44 age groups, respectively. The increase in men for 15-19 age group 
was 0.1%, and for the 40-49 age groups, it increased by 1.6%. Meanwhile, even though 
the HIV prevalence trend for men age 15-49 declined, the change was not statistically 
significant for the period between 2005 and2011.  
HIV prevalence in the future. Hailay, Paul, Kifle, and Lillian (2017) showed the 
likelihood of increasing or relapsing of HIV prevalence in Ethiopia after 2016 because of 
high ART defaulters’ rates (22.3%); however, the time series analysis result of this study 
shows, unless unforeseen internal and external factors affect the trend, the HIV 
prevalence will continue to downfall from 2.7% in 2017 to 0.7% in 2025 for urban, from 
0.4% in 2017 to 0.2% in 2025 for rural, and from 0.9% in 2017 to 0.5% in 2025 for the 
country, Ethiopia. The justification given by Hailay, Paul, Kifle, and Lillian for the 
likelihood of increasing of HIV prevalence to the future was linked to the decreased trend 
of adhering to ART. According to this study, one out of five Ethiopian dropped from 
taking ART and those who withdraw from the treatment (usually women and 
80 
 
 
 
HIV/tuberculosis co-infected people) are more likely to contribute for further 
transmission of HIV. 
Comparison of Funding Level Findings with Literature  
Ethiopia spends 3 to 5% of their GDP on health, which makes annual per capita 
health spending less than $25, while foreign funding covers 30 to 50%. In 2012, the total 
money spent for HIV/AIDS in Ethiopia was $ 405 million, of which $350 million (86%) 
was obtained from external sources, $55 million (13%) from public income, and 
$680,000 (0.2%) from the private sector (WHO, 2013). Though health spending in 
Ethiopia had similar trends for many years, since 2008, funding from external donors is 
flat lining or decreasing (Vassall et al., 2013).The reasons for declining funding levels 
were decreases in both bilateral and multilateral funding, which accounts for a 50% drop 
of funding levels, exchange rate variations, which accounts for a20% drop of funding 
levels, and U.S. contributions to the Global Fund to Fight AIDS, Malaria, and 
Tuberculosis, due to the law that limits its funding to one-third of total contributions to 
the Global Fund (Jen & Adam, 2017). Therefore, one of the objectives of this study was 
to know if this funding decrement is correlated with HIV infection rates or prevalence 
trends. Accordingly, the results of this analysis showed that there is a positive correlation 
between funding from donors in terms of HIV prevention, care, and support, and national 
HIV prevalence. The positive correlation coefficient (.635) indicates that there is a 
statistically significant (p = .027) linear relationship between these two variables such 
that the lower HIV prevalence level the country has nationally, the smaller the funding 
level from donors is. An empirical research finding that was conducted by Azuine et al. 
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(2014) on the impact of international humanitarian assistance on combating HIV/AIDS 
had also showed that the decrease of donor assistance in developing countries followed 
an overall reduction of HIV infection rates.  
According to the finding of this study, while the prevalence of HIV decreased 
from 1.4% to 1.1% between the years 2011 to 2016, the PEPFAR fund was decreased by 
57%. Though this decrement follows the descent of prevalence, it doesn’t seem 
proportional and may cause shortage of fund to carryover started programs appropriately. 
As Samji (2013) illustrated that defunding the HIV/AIDS program disproportionately 
may cause catastrophic phenomenon like flaring up the disease again as HIV drugs are 
not curing AIDS and should be taken life-long. This was also supported by UNAIDS 
(2017) because ending HIV/AIDS depend largely on the funding level and ability to 
provide HIV treatment to all who need it. In the meantime, nowadays, Ethiopia adopted 
the global 90–90-90 HIV prevention targets by 2020 which is part of strategies designed 
to eliminate HIV/AIDS epidemics by 2030; and to attain these targets funding level will 
remain to be a critical area.  
Last, according to MoH (2014), the proportion of spending HIV budget by 
regions shows that 43% was expended by federal/central government, 13% in Amhara, 
13% Addis Ababa, 11% Oromia, 8% South Regions, and 22% for the remaining seven 
regions or towns and this distribution considers the prevalence and total population in 
each region. This spending proportion was in concurrence with the finding of this 
analysis except the deviation observed in two regions, Gambella and Tigraye. The 
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investment to HIV prevention, care, and treatment along with the HIV prevalence trends 
hasn’t been correlated in those two regions, r = .375, p =.229.  
Comparison of Findings Regarding Service Areas and Funding 
According to FHAPCO (2012), the expenditure of money from all external 
sources disperse as 30.9% for HIV treatment, 19.5% for prevention, 29.7% for national 
system strengthening and program coordination, and 6.8% for OVC support.  This 
distribution of funds was also similar to the finding of this analysis for the remaining 
years. The two main external sources of fund for HIV prevention, care, and treatment are 
PEFPAR and Global Fund. While 31% of PEPFAR’s support goes to national systems 
strengthening and program management, 27% and 17% go to treatment and care, and 
prevention, respectively. On the other hand, 51% Global Fund share goes primarily to 
treatment; and the remaining 28% and 9% go to systems strengthening and program 
management and prevention, respectively. In relation to the finding of this study, the type 
and number of HIV service in the study period were influenced by the funding level from 
the donors’ community. The number of people served for different service areas were 
varied with the total funding level, but proportional. Adjusting the number and type of 
services with the level of funding could be applicable for some services; however, it will 
not be always applicable as some service areas are sensitive. For instance, while this 
analysis is done, there are 460,564 people on ART and they need to get their treatment 
for their life time unless cure is possible in the future. This activity, unlike other 
activities, can’t be discontinued because funding level is decreasing. Therefore, even 
though there is a statistically significant (p < 0.05) association between the number and 
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type of HIV related services and funding level, some activities like ART need to get due 
attention.  In general, to know whether the funding breakdown by thematic area is a cost-
effective way of investment or not, further studies shall be considered in the future.  
HIV Prevalence by Socio-demographic Characteristics 
One of the aims of this analysis was to determine the important factors that fuel 
the HIV prevalence among variable that were used in the three EDHSs. Therefore, the 
effect of different Socioeconomic and Demographic Characteristics on trend of HIV 
prevalence in the past ten years was analyzed using a multiple regression. The analyses 
discovered that the odds of HIV infection were generally elevated among widowed and 
divorced women. When the current marital status of sampled people assessed, 77% and 
93% widowed were women in EDHS2005 and EDHS 2011, respectively. The number of 
divorced women was also found high in both surveys. Among the divorced sampled 
people, 91% were women in EDHS 2005, 77% in EDHS 2011, and 83% in DHS2016, 
which has a good degree of association with fair quality of prediction or the likelihood of 
getting HIV increases based on the current marital status. This finding was confirmed 
with a number of studies. A study conducted by (Rand & Daniel, 2004) in Kampala and 
Lusaka on HIV within behavioral risk groups identified a significant rate of infection 
among divorced and widowed women followed by singles. This was also consistent with 
another study conducted by (Mmbaga et al., 2007) in Arusha, Tanzania, revealed that the 
HIV prevalence is higher in divorced and separated individuals compared to cohabiting 
and married couples. Another analysis from 13 sub-Saharan Africa countries also has 
discovered that separated and widowed individuals are at higher risk of acquiring HIV 
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than single or married, especially if they are females. For example in Cote d’ivoire13% 
versus 6%, Kenya 17% versus 8%, Lesotho 46% versus 26%, Ethiopia 6% versus 1%, 
Rwanda 12% versus 2%, and Zimbabwe 46% versus 17% the prevalence of HIV was 
higher in divorced and remarried women than others (de Walque & Kline,2012). 
Age at first sexual intercourse was also one of the important variables found to 
have strong association with HIV prevalence. Accordingly, this study has recognized a 
significant rate of infection among women with early sexual debut. For both sexes who 
first had sex after the age of 20, the HIV prevalence was low. However, women who first 
had sexual intercourse at the age 18 or below had a prevalence of 1.9% while men who 
reported first sexual intercourse at age 16 had a prevalence of 1.4%. Similar studies have 
discovered that higher level of infection among girls than boys of same age because of a 
number of facts. According to Hallett et al. (2007), during young age, girls usually make 
sex with older men while boys have sex with girls having relatively similar ages. Poverty 
usually motivates many girls to have sexual intercourse with older men or ‘sugar daddies’ 
and 90 percent of HIV infections contributed by 15 – 24 years old women (Jewkes, 
1999). For both sexes, HIV prevalence increases with increases number of sexual 
partners. The prevalence of HIV among women increases from 0.8% to 7% while the 
number of lifetime sexual partners increase from one to 10 or more. However, this level 
of exposure is lower for men, and hence, it grows from 0.3% to 2.9% with 10 or more 
lifetime sexual partners. This finding was also confirmed by another study conducted by 
Hallett et al. (2007) that shows how age at first sex is associated with HIV infection. 
According to this study that was conducted in Zimbabwe, women who started sex at the 
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earlier age are more likely to be infected by HIV as they will have many lifetime sexual 
partners than those who stayed abstain from sex in their teenage.    
Place of living or place of residence was also identified as a potential factor 
affecting the prevalence of the epidemic because of the socio-economic and socio-
cultural variation in between rural and urban areas. Among sampled people for this study, 
34% were from the urban areas. In the meantime, the finding depicted that people living 
in urban areas are at higher risk of acquiring the disease than rural dwellers. In rural areas 
as there is high influence of traditional values and limited sexual network, the prevalence 
is low. Therefore, in urban areas, HIV prevalence is seven times higher (2.9% versus 
0.4%) than in rural areas for both sexes. While we see separately for women and men, 
urban HIV prevalence for women is 3.6% and the rural prevalence is 0.6% while the 
matching percentages for men are 2.0% and 0.2%, correspondingly. 
In many study findings, educational status mentioned as one of the important 
socio-economic factors affecting the AIDS epidemic all over the world. Accordingly, in 
this study even though the impact of education on prevalence of HIV was not found 
statistically significant (p =.132), the result showed that people who completed primary 
school are at higher risk of getting the disease than illiterate or no education. As it is 
believed, education improves the awareness of individuals to access different information 
about the epidemic and get services in addition to improving personal income in the long 
run. According to Fylkesness et al. (1998), getting HIV infection is growing significantly 
with increasing educational status or accomplishment in rural and urban inhabitants of 
Zambia. Another study done in Zimbabwe had also showed that educated persons have 
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higher risk getting HIV infection in Africa because of the fact that people have possibility 
of changing sexual partners frequently (Mmbaga et al., 2007). 
Another socio-economic factor that was assessed for its effect on prevalence of 
HIV epidemic was wealth quintile. Like the educational attainment, despite the fact that 
wealth of individuals was not a statistically significant determinant factor for HIV 
prevalence in this study finding (p = .991), there is a trend showing that people in the 
highest wealth quintile have a higher HIV prevalence. For instance, among women 
sampled in EDHS 2016 and with highest wealth quintile, the HIV prevalence was 3.0% 
while women in lower wealth quintiles (poor) had 1.0% prevalence. Nevertheless, the 
discriminatory attitudes and knowledge of prevention methods were increased with 
increased wealth quintile for both women and men. Other studies have also showed the 
impact of poverty in limiting media exposure, cause for migration of people, lessen 
access to health education and nutrition, and increase sexual exploitation (Casale & 
Whiteside, 2006). Meanwhile, the available study findings on the relationship between 
poverty and HIV/AIDS are inconsistent. Casale and Whiteside (2006) showed that HIV 
infection doesn’t disproportionately affect the poorer in sub-Saharan Africa; and people 
in the wealthiest quintile have a higher HIV prevalence than those in the lower wealth 
quintiles (poorer quintiles). According to Mmbaga et al. (2007), this finding was 
supported by stating that wealthier people tend to have higher HIV prevalence than 
poorer people. To the reverse, a study done by Bloom et al. (2002) revealed that poverty 
is a key factor for HIV transmission because it increases people exposure to the virus.  
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Findings in the Context of the Theoretical Framework 
 
I applied the proximate determinant framework to examine the association of 
proximate variables, like funding level for Anti-HIV/AIDS activities, socio-demographic 
characteristic, and service areas to learn if these have a direct effect on the outcome 
variable and influence the change of it. Accordingly, the five most important proximate 
determinants for men and women were current marital status, employment (last 12 
months), number of lifetime partners, place of Living, and age at first sexual intercourse, 
which are potential to change or affect or interfere and have immediate effects on the 
outcome, HIV prevalence. In addition, the linear relationships between the donors’ 
financial support and prevalence have been measured.  
Based on the guiding principles of the proximate determinants conceptual 
framework, the marital status found to be one of the variables that affect the HIV 
prevalence. Women and men reported ever having been married had higher probability of 
acquiring HIV than those who have never married. Meanwhile, the highest HIV 
prevalence noticed among the widowed and divorced people. According to this 
conceptual framework, married people have higher risk level than unmarried; and hence, 
while the HIV prevalence for never married women and men in 2005 and 2011 were 
0.7% and 0.2%, respectively; divorced and widowed were positive by 8.1% and 5.6%, 
respectively, in 2005; and 5.9% and 14.5%, respectively, in 2011. This shows that 
married are six times more likely (OR = 6.51 95% CI = 3.49–5.44%), and widowed are 
twenty times more likely (OR = 19.94, 95% CI = 16.04–24.79%) than unmarried to 
acquire HIV. 
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HIV prevalence also differs remarkably by employment status. The risk of 
unemployed for the epidemic is lower than employed people because of a number of 
reasons including movement to other places for work and income, which is highly 
correlated with wealth. Wealthy individuals usually have wider social and sexual network 
and are at higher risk of getting the infection. The conceptual framework has also showed 
as the number of lifetime sexual partners has a huge impact to raise the likelihood to be 
infected in both sexes though the risk is much higher for females. This was illustrated in 
both the three EDHS findings. While the prevalence of HIV in people with one lifetime 
sexual partner is less than 1 percent, it may go up to the level of 7 percent for those who 
have multiple lifetime sexual partners. In addition, this theoretical framework has 
highlighted the prevalence difference in place of living. In the rural community where the 
overwhelming majority of Ethiopians are living, the prevalence of HIV has been noted 
very low in the study periods because of the strong traditional values and less sexual 
networking. According to EDHS (2011), the urban areas in Ethiopia are seven times 
more affected with the prevalence than rural areas. 
Limitations of the Study 
This study was based on data that were collected in the previous three 
Demographic and Health Surveys (DHS) of Ethiopia. Those surveys, like any other DHS, 
were nationally-representative household surveys and contain a wide range of indicators 
about health, nutrition, and population. Accordingly, generalizability was not an issue. 
However, to provide estimates for small regions, DHS samples were not large enough 
and, in some extent, it was affecting the generalizability; otherwise, the findings and 
89 
 
 
 
conclusions from DHS were generalizable and trustworthy. Getting the actual spending 
amount for HIV related services had limitation because some partners’ accounting 
information systems do not contain specific budgetary and expenditure lines and 
comprehensive expenditure records. Because of this, under-estimation or overestimation 
was not ruled out. In addition, all predictors of HIV: demographic – ethnicity, country by 
birth, and sexuality; behavioral – condom use, unsafe sex, alcohol use, substance use, 
male sex with male, and multiple sexual partners; clinical – weight loss, fever and chills, 
cough, diarrhea, respiratory tract infection, oncology, and hematology were not included 
as they were not in EDHS data; and hence, internal validity, estimate truth about 
inferences concerning causal relationship, could be affected. The other limitation for 
working with survey datasets was that datasets are compressed .ZIP files contains 
multiple working files along with data definition files but getting the instruction file to 
work with ZIP files was challenging.  
Recommendations 
There are several recommendations that might advance findings in progressing 
the curve of HIV prevalence, enhancing financial sustainability, targeting effective 
responses, and work on specific and to the right predictors. First, although there is an 
advancement in relation to HIV prevalence in the country, which remains to be 
categorized by a low-intensity, mixed epidemic with significant heterogeneity, it is 
meaningfully differ in between geographical areas (6.6% in Gambella, 5.0% in Addis 
Ababa, and 0.7% in Southern Nations, Nationalities and Peoples’ (SNNPR) region. 
Therefore, it is advisable to sort out and categorize regions as per their HIV burden and 
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prioritize them to address the greatest unmet needs first. In those geographic areas with 
greatest unmet needs or high prevalence, community and facility-based testing services 
and HIV Self-Testing shall be strengthened, access to treatment services shall be 
improved to accelerate ART linkage and the Test and Start, and make stronger the active 
disclosure support and targeted demand creation for testing. Second, to have constant and 
expanded funding mechanisms in place to fund the AIDS responses, there should be a 
thought of alternative sources of public revenue and domestic investment to transition 
from donor support to a sustainable domestic response; collaboration with all donors, 
civil society organizations and private sectors; and finding innovative ways of funding 
the responses by self. More countries have been stated for considering innovative 
financing mechanisms to raised resources for HIV like Zimbabwe, a 3% tax on all 
formally employed individuals; Rwanda and Uganda taxes on mobile phone usage; 
Congo, Madagascar, Mali, Mauritius, and Niger from an airline tax (African Union, 
2013). Third, in order to address the problem related to funding level decrement, vigorous 
financial tracking system should be in place to understand the funding trends and its 
relationship with type or number of responses to prevent and control HIV/ADS. Knowing 
the type or number of services that are critical and effective will enable to use the scarce 
resource appropriately and bring the desired impact shortly. Meanwhile, since this study 
had some limitation to get adequate service related data, I propose to conduct a mixed 
method research to identify which service is more contributing to end the epidemic. 
Fourth, findings of this study recommend to give due attention for following segment of  
population with highest HIV transmission: widowed and divorced men and women, 
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unemployed men and women, people who have less than three life time sexual partners, 
children who practiced their first sexual intercourse before the age 16, urban inhabitants, 
and people with highest wealth quintile. However, as stated on the limitation of this study 
section, as many other important predictors of HIV were not in EDHS data, I suggest the 
need for further investigation to know the drivers of the epidemic in a better way.  
Implications for Professional Practice and Social Change 
Professional Practice 
This section provides recommendations to professional practice and positive 
social change implications relevant to knowing the association between HIV prevalence 
and funding level and identifying the socio-economic and demographic factors that fuel 
the epidemic. I am managing this study to be a good examiner and provide clues on how 
to ensure the HIV response is sustainable. If the response becomes sustainable, it empowers to 
have an enabled environment, appropriate services, conducive system, and resources essential to 
effectively and efficiently control the HIV epidemic. Accordingly, in the following subsections, I 
am describing methodological, theoretical, and empirical implications to professional 
practice.  
Methodology. This analysis could be improved by using mixed method research. 
The secondary data can still provide a supporting role in the study, but to assess the 
socio-economic and demographic factors that driving the epidemic, both qualitative and 
quantitative design could give a better result to answer the research questions. According 
to Creswell and Plano Clark (2007), mixed method is more than merely gathering and 
examining both types of data; likewise, it includes the use of both methods in the process 
so that the general strength of a study is better than either of the two designs. 
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Theory. In this study, I attempted to combine demographic, behavioral and 
epidemiological approaches to develop a conceptual framework for the study of the main 
factors determining the HIV epidemic in the population. However, this framework 
initially has been used comprehensively in the study of fertility and child survival to 
measure the association between biological, personal, cultural, environmental, and 
behavioral factors and their influence on human fertility (Boerma & Weir, 2005). 
Accordingly, while this framework was used in this study, the objective was to recognize 
a set of variables, called “proximate determinants,” that can be influenced by changes in 
circumstantial variables or by interventions that have a direct effect on the outcomes; and 
to tease-out factors affecting HIV vulnerability. Thus, even though extensive literature 
review has been made on the application of the framework, fine-tuning and modifying 
this framework may be needed to make it pertinent to capture the predominant situation 
in the particular study area and to quantify these situations within the variables at each 
stage of the framework.   
Empiricism. I propose that the empirical implication for this trend analysis may help 
to promote the way how HIV prevalence and funding levels are correlated and affect the 
scope of the response. Information obtained through trend analysis would tell what was 
happening in the past, being going on now, and forecasting future patterns of the health-
related issues, which in turn is significant in fine-tuning public health policy and 
interventions (Rothman, 1998). In addition, systematically reviewing the effect of 
predictor variables will use to be more selective in the process of implementation and to be 
focused on the target while investing on HIV with limited resource as international 
assistance from donors is either declined or remained flat. A systematic review is 
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indispensable to perceive lifestyle, clinical, demographic, and laboratory characteristics 
of patients which might be connected with HIV infection in primary care; and 
analytically assess and understand available evidences to act with the right measure 
(Norman &Griffiths, 2014).  
Positive Social Change 
The findings support Walden’s mission by providing recommendations to 
professional practice and positive social change implications relevant to knowing the 
association between HIV prevalence and funding level and identifying the socio-economic 
and demographic factors that fuel the epidemic. The aim is to examine the trend of HIV 
prevalence and funding levels and analyzing those data if the funding shortfalls are 
subjected to threaten the gains made on HIV prevention strategies in the future. This 
study suggests at the individual and family level that cognitive, social, and technical 
competencies and skills associated with safer sex and drug use practices need to be 
improved and be supportive for HIV preventive practices. At the organizational level, 
there is a need to critically analyze and synthesize HIV/AIDS studies to establish critical 
issues and indicators that may explain the driving forces of the epidemic and trends, and 
inform the healthcare decision-makers with findings of the four research questions so that 
they will place more value on such works in their deliberations and in their interactions 
with stakeholders for sustainable financing initiatives. At societal or policy level, it will 
help to bring changes in the system of implementation; and find the best solutions to HIV 
epidemic control and prevention strategies, which is the most burdensome health 
problems, by meet the long-term needs of people living with the problem. 
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Conclusion 
The objective of this study was to examine the trend of HIV prevalence and 
funding levels from donors’ and analyzing how these variables are correlated and 
affected the scope of the response. Accordingly, the results were important because it 
illustrated the trends in HIV prevalence over time and concluded: a) even though the 
trend in changing prevalence in the first and second five years was found to be different; 
in general, the national HIV prevalence was declining significantly over the ten-year 
study period, b) there was a regional variation in prevalence density among all ages, c) 
the association between HIV prevalence and funding levels from donors is statistically 
significant and have a positive linear relationship, c) a significant associations and 
meaningful effect of funding on who gets what services, on what frequency, and how 
responses are highly depend on the amount of fund available, and d) the prevalence of 
HIV was not the same for all socioeconomic and demographic characteristics and 
presented population subgroups that are with higher risk of HIV-infection. However, as 
the source of data for this study was DHS, the limitations of using secondary data could 
apply here and definitive conclusions about the relationships between HIV prevalence 
and funding level cannot be made via correlation analysis alone. Therefore, additional 
national rigorous analysis are needed to comprehend the associations between 
programmatic efforts, funding level, reported behavioral change, and changes in 
prevalence of HIV. 
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